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ABSTRACT 
Meiosis is the process by which diploid germ cells develop into competent haploid 
gametes. In female mammals, meiosis is characterised by two periods of arrest, the 
duration of which is species-specific. This study investigated the first period of 
meiotic arrest which occurs at the diplotene stage of prophase I. This period of arrest 
has important implications for artificial reproductive technologies as the maintenance 
of meiotic arrest in the in vitro situation has been correlated with improved 
embryological outcomes. Despite there being extensive evidence that the somatic 
cells of the follicle (granulosa and cumulus cells) produce meiosis-inhibiting factors, 
the factors themselves and the mechanisms through which they act are unclear. 
Recent evidence implicates C-type natriuretic peptide (CNP) and oestradiol in the 
regulation of meiotic arrest in mouse oocytes. In this proposed hypothesis, CNP is 
produced by the granulosa cells and activates its cognate receptor, NPR2, on 
cumulus cells. This results in the production of cyclic guanosine monophosphate 
(cGMP) in cumulus cells which is transferred to the oocyte via gap junctions. In the 
oocyte, cGMP slows the rate of hydrolysis of cyclic adenosine monophosphate 
(cAMP) by phosphodiesterase 3A resulting in elevated intra-oocyte cAMP levels. By 
maintaining high levels of cAMP in the oocyte, maturation-promoting factor (MPF) 
activity is inhibited, preventing re-entry into the cell cycle, thus maintaining meiotic 
arrest. The overall objective of this study was to investigate the validity of this 
aforementioned hypothesised regulatory pathway in another mammalian species, 
the rat. Four fundamental components of this pathway were chosen to be 
investigated and these framed the four aims of this study.  
The aims of this study were to investigate in cultured rat cumulus cell-oocyte 
complexes (COCs) the short and long-term effects of CNP and oestradiol, both alone 
and in combination on (1) gap junction permeability using a validated gap junction 
assay, (2) intracellular cGMP levels using a direct competitive immunoassay, (3) 
mRNA expression levels of key cumulus cell-derived genes (Npr2, the receptor for 
CNP; and Pde4b and Pde4d, phosphodiesterases) using an optimised multiplex 
TaqMan qPCR reaction, and (4) duration of meiotic arrest. 
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Overall, the results of this study indicated that the assessed treatments did not alter 
gap junction permeability in rat COCs in vitro. Whilst treatment with CNP and 
oestradiol appeared to increase the intracellular levels of cGMP in COCs, this 
requires further investigation. Notably, this study confirmed the role of steroid 
hormones in upregulating Npr2 expression. Indirect evidence suggests that PDE4D 
in particular, is a major regulator of cyclic nucleotide levels in the cumulus cells. 
Finally, treatment of rat COCs with CNP and oestradiol increased the duration of 
meiotic arrest in oocytes incubated in vitro. 
The results of this study provide the first evidence that the hypothesised regulatory 
pathway proposed above is also relevant in the rat. Nonetheless, further 
investigation of the effects of CNP and oestradiol on the modulation of intracellular 
cGMP levels are required to fully validate the model. 
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Chapter 1: Introduction 
1.1. The Ovary 
The mammalian ovary has two main functions. Firstly, it is the organ within which the 
female gamete, the oocyte, develops and matures. Secondly, the ovaries are a 
major endocrine gland, producing a number of hormones and regulatory proteins, 
including 17β-oestradiol and progesterone, which have a plethora of local and 
systemic effects. These functions are not independent of each other as the 
hormones produced by the ovary are required for the latter stages of oocyte 
maturation and are instrumental in regulating the recruitment of growing follicles, and 
the induction of follicular growth, follicle maturation and ovulation.  
The ovaries are a pair of ductless glands that are located on either side of the uterus 
in female mammals. The ovary is comprised of two regions (cortex and medulla) that 
differ in function (Tortora, 2003). The ovarian follicles are located in the cortex which 
is encapsulated by the surface epithelium. The medulla is located in the centre of the 
ovary and is comprised of dense connective tissue as well as blood and lymphatic 
vessels, and nerves.  
1.1.1. Folliculogenesis 
In those species (e.g. humans, mice and sheep) in which this has been rigorously 
studied, it has been revealed that the primordial germ cells migrate to the gonadal 
ridge during embryogenesis (Chiquoine, 1954; Zamboni et al., 1979). Upon reaching 
the prospective gonad, the primordial germ cells differentiate into oogonia and form 
germ cell clusters within isolated regions termed ovigerous cords. Within these 
ovigerous cords, oogonia substantially increase their numbers by mitosis and 
primitive granulosa cells are recruited from the ovarian surface epithelium to 
associate with these proliferating oogonia. During this time, oogonia are also 
undergoing either apoptosis or initiation of meiosis. The healthy oogonia that enter 
meiosis and subsequently arrest at the prophase stage of meiosis I are termed 
oocytes. Each oocyte is surrounded by a complement of granulosa cells and bud off 
from the base of the ovigerous cords. The formation of these non-growing primordial 
follicles marks the beginning of folliculogenesis (Braw-Tal, 2002; Sawyer et al., 2002; 
van den Hurk and Zhao, 2005).  
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Figure 1-1: The stages of folliculogenesis, including the formation of the antrum and the 
gonadotropin-independent, gonadotropin-responsive and gonadotropin-dependent 
phases.The transition from the pre-antral to the antral stages of follicular growth also marks 
the transition after which the oocyte has the ability to attain meiotic competence. That is, 
removal of the oocyte from these follicles results in spontaneous meiotic resumption, as is the 
case during in vitro culture. Modified from a diagram supplied by Lisa Johnston. (VUW 
BBMedSci Honours thesis, 2010).  
The initiation of follicular growth is marked by a change in cell morphology as the 
granulosa cells surrounding the oocyte within primordial follicles change from 
squamous to cuboidal in shape. Following this transition, the follicle is now termed a 
primary follicle. Recruitment to the pool of growing follicles is a continuous process 
that is dependent on the order in which follicles are formed. The first follicles that are 
formed, are the first to begin growing and they grow continuously until they die or 
ovulate (Edwards et al., 1970). This process of recruitment and growth begins 
coincidently with the formation of primordial follicles (Edwards et al., 1970) and in 
women and other species, this process continues until this finite pool of follicles is 
exhausted (Peters et al., 1975; Richardson et al., 1987). 
In response to paracrine signals from the oocyte, such as oocyte-secreted factors 
(OSF), the granulosa cells of a primary follicle proliferate to form multiple layers 
surrounding the oocyte, an event that marks the transition to a secondary follicle 
(Figure 1-1) (Yang and Fortune, 2008). The oocyte is thought to dictate this 
transition. Evidence for this includes reports of oocytes that were removed from 
secondary follicles and inserted into primordial follicles and these have been found to 
increase the rate of follicular development to the extent that these primordial follicles 
appeared morphologically similar to secondary oocytes (Eppig et al., 2002). Two 
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OSF, namely growth differentiation factor 9 (GDF-9) and bone morphogenetic 
protein 15 (BMP-15) have been shown to stimulate proliferation and differentiation of 
the granulosa cells which is essential for normal follicular development in some 
species (Hayashi et al., 1999; Eppig et al., 2002).  
The majority of oocyte growth is completed during the pre-antral stages in secondary 
follicles and subsequent formation of a fluid-filled antrum is heavily influenced by the 
oocyte. As the number of granulosa cells increase, small fluid-filled spaces begin to 
form between the granulosa cells and these coalesce to form a large fluid-filled 
cavity (Hirshfield, 1991). Antral or follicular fluid is hypothesised to be a product of an 
osmotic gradient generated by the production and secretion of hyaluron and versican 
by the granulosa cells and results in increased fluid accumulation and retention in 
the follicle (Rodgers and Irving-Rodgers, 2010). Antrum development results in the 
differentiation of the homogenous granulosa cell population into two distinct 
populations, the mural granulosa cells and the cumulus cells (Figure 1-1) (Sugiura 
and Eppig, 2005). The mural granulosa cells are mainly involved in steroidogenesis 
whilst the cumulus cells remain associated with the oocyte to provide substrates and 
metabolites critical for oocyte maturation (Armstrong et al., 1996; Carabatsos et al., 
2000).  
The formation of the antrum also indicates a transition from the gonadotropin-
independent phase to the gonadotropin-responsive and then gonadotropin-
dependent phase of follicular development (Scaramuzzi et al., 1993; Edson et al., 
2009; Sirard, 2011; Zhang and Xia, 2011). Without the appropriate stimulation by 
pituitary-derived follicle-stimulating hormone (FSH) and luteinising hormone (LH), the 
fate of the gonadotropin-dependent follicles is atresia. Thus sexual maturation and 
puberty are essential milestones that must be attained before folliculogenesis can be 
completed (i.e. development from primordial follicles to the ovulation of a mature 
oocyte). Puberty coincides with neuronal development in the hypothalamus that 
results in the hormonal interplay between the pituitary gland and the ovaries in all 
reproductively-active mammals. In all mammals, the late luteal or initial follicular 
phase of the oestrous cycle is dominated by high concentrations of FSH that 
supports the growth of antral follicles, however, this declines due to increasing 
follicular oestradiol production. The increasing levels of oestradiol eventually lead to 
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the stimulation of a pre-ovulatory surge of LH which triggers ovulation in the pre-
ovulatory follicle(s).  
1.1.2. Meiosis and Meiotic Arrest 
The development of competent haploid gametes (i.e. oocyte or spermatozoa) from 
diploid germ cells (i.e. oogonia or spermatogonia) occurs by the process of meiosis 
(Figure 1-2). In female mammals, the process of meiosis is characterised by long 
periods of arrest. The first of which begins during foetal development when oocytes 
enter the diplotene stage of prophase I and this arrested stage of maturation is 
maintained, even in growing follicles, until just prior to ovulation when the pre-
ovulatory LH surge occurs (Sirard, 2001; Mehlmann, 2005a; Zhang and Xia, 2011). 
The duration of the first meiotic arrest is species-specific and dependent upon the 
timing of puberty and life expectancy of each species or in those species that 
undergo menopause, the timing of depletion of the ovarian follicular reserve. 
Consequently in women, some oocytes may be in meiotic arrest for approximately 
40 years (Tripathi et al., 2010). In most species, there are two periods of meiotic 
arrest. Following the resumption of meiosis from the diplotene stage of prophase I, 
the second arrest occurs at metaphase II. Meiotic resumption after this point is 
dependent on successful fertilization of the oocyte (Whitaker, 1996). 
Oocytes that are in meiotic arrest at the diplotene stage of prophase I are 
morphologically identifiable when viewed under a microscope due to the presence of 
the germinal vesicle (GV; Figure 1-3). The GV is the visible nuclear membrane which 
contains partially-condensed chromosomes and a prominent nucleolus (Zhang and 
Xia, 2011). Breakdown of the GV (GVBD) is considered an endpoint marker of the 
completion of nuclear maturation in the oocyte and the cessation of meiotic arrest 
(Mehlmann, 2005a; Zhang and Xia, 2011). At meiotic resumption, prophase I is 
completed and extrusion of the first polar body occurs. 
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Figure 1-2: The stages of meiosis in relation to developmental events in female mice. Key 
events during the stages of meiosis I are described in relation to days post-coitum (dpc) and 
the two periods of meiotic arrest are indicated by black arrows. This diagram also describes 
changes in chromosome number that occur during meiosis. A reductive division at the end of 
meiosis I result in the haploid (1n) oocyte and extrusion of the first polar body (n – the number 
of chromosomes, in the mouse n=20 and rat n=21). (Modified from Bowles and Koopman, 
2007.)  
It is during the antral phase of follicular development that oocytes acquire meiotic 
competence, defined as the ability to resume meiosis spontaneously when removed 
from the follicular environment (Mehlmann, 2005a). Interestingly, oocytes from antral 
follicles, but not primordial and primary follicles (Mehlmann, 2005a), will undergo 
spontaneous meiotic resumption when removed from the follicular compartment and 
cultured in vitro. As such, it has been hypothesised that the follicle and in particular, 
the somatic cells (the granulosa and cumulus cells) of the follicle play a key role in 
the maintenance of meiotic arrest, through the production of meiosis-inhibiting 
factors (Pincus and Enzmann, 1935). 
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Figure 1-3: Photomicrographs of denuded rat oocytes with (A) and without (B) a germinal 
vesicle (GV).The oocyte in A has a clearly visible GV, as indicated by the white arrow. 
Conversely there is no visible GV in the oocyte in B, indicating the initiation of GV breakdown.  
1.2. Gap Junction Communication 
The somatic cells of the follicle are physically and metabolically coupled to each 
other and the oocyte by gap junctions. These gap junctions are involved in supplying 
essential ions, amino acids and metabolites (<1000 kDa) to the oocyte. In addition, 
gap junctions are involved in the transport of other regulatory molecules, including 
cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate 
(cGMP) which have been shown to be essential for the maintenance of meiotic 
arrest (Gilchrist et al., 2008). The cumulus-oocyte complex (COC) contains both 
homologous (between the somatic cells) and heterologous (between the somatic 
cells and the oocyte) gap junctions. Gap junctions are composed of proteins called 
connexins (Figure 1-4). The connexin proteins that form the gap junctions within 
ovarian follicles are connexin 43 (Cx43) and 37 (Cx37). In the COC, the Cx43 protein 
is translated in gap junctions that couple the cumulus cells while Cx37 protein is 
translated exclusively in the gap junctions that couple the oocyte to the cumulus cells 
(Mayerhofer and Garfield, 1995; Veitch et al., 2004). 
Studies in Gja4 (the gene encoding the Cx37 protein) knockout mice indicate that the 
presence of heterologous gap junctions are essential for folliculogenesis as the 
ovaries of these mice contained few or no late pre-antral or antral follicles. Thus the 
Gja4-/- mice were sterile with smaller oocytes when compared to that in wild-type 
mice (Simon et al., 1997; Carabatsos et al., 2000). In addition, the oocytes from 
these follicles were less meiotically-competent when compared to follicles from 
control mice. These results suggest that oocyte growth and granulosa cell 
proliferation is dependent upon gap junction activity. 
A B
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Likewise, studies in Gja1 (the gene encoding the Cx43 protein) knockout mice have 
indicated a pivotal role for this protein in the maintenance of follicular development. 
These Gja1-/- mice had fewer germ cells than wild-type mice, but as Gja1-/- mice die 
soon after birth, an organ culture technique was used to assess post-natal 
folliculogenesis. These studies revealed that there were no observable secondary 
follicles in the ovaries and confirmed the role of Cx43 in folliculogenesis (Juneja et 
al., 1999; Ackert et al., 2001). These results suggest that oocyte growth/hypertrophy 
is gap junction dependent (Juneja et al., 1999).  
In the in vivo situation, the extensive metabolic and developmental coupling of the 
oocyte and somatic cells is essential for the maintenance of meiotic arrest in antral 
follicles that have not been exposed to a pre-ovulatory LH surge (Eppig et al., 2002; 
Zhang and Xia, 2011). Early evidence indicated that the cessation of gap junction 
communication occurs coincidently with GVBD (Eppig and Downs, 1987). However, 
there is evidence that the disruption of gap junction communication precedes GVBD. 
It is now understood that the onset of GVBD occurs once the level of gap junctional 
communication drops below a certain level. For example in the bovine COCs, GVBD 
is initiated once gap junction activity declines to 40% of the original level of 
communication, as measured by a gap junction assay (Thomas et al., 2004). In the 
in vitro situation, pharmacological disruption of gap junctions using the blocking 
agent carbonexolone resulted in resumption of meiosis in oocytes of treated follicles 
(Sela-Abramovich et al., 2006). 
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Figure 1-4: The formation and structure of gap junctions. Gap junctions can be composed of 
one or more different connexin proteins. In the COC, the connexins involved in the formation 
of gap junctions are Cx37 and Cx43. Hemichannels or connexons are made up of 6 connexin 
proteins. Each of the cells contributes one hemichannel and once connected to a hemichannel 
in the adjacent cell forms a gap junction. This figure is from Campen (2013), with permission.  
1.3. Cyclic Nucleotides and Phosphodiesterases in the Follicle 
The accepted dogma is that meiotic arrest is directly maintained by high 
concentrations of cAMP within the oocyte (Mehlmann et al., 2002). The mechanism 
of action involves high cAMP levels that activate protein kinase A (PKA) and result in 
the subsequent phosphorylation and suppression of maturation-promoting factor 
(MPF) activity, thus preventing re-entry into the cell cycle (Mehlmann, 2005a; 
Vaccari et al., 2008). 
1.3.1. Cyclic AMP 
Experimental manipulation to increase cAMP levels in oocytes cultured in vitro using 
pharmacological agents that either stimulate cAMP levels or prevent cAMP 
hydrolysis have been shown to prolong meiotic arrest. For example, two commonly-
used cAMP analogues dibutryl cAMP (dbcAMP) and 8-bromoadenosine cyclic 
monophosphate (8-bromo cAMP) have both been shown to prolong meiotic arrest in 
mouse and bovine oocytes in vitro (Cho et al., 1974; Aktas et al., 2003). 
Furthermore, the use of phosphodiesterase (PDE) inhibitors to suppress the 
hydrolysis of cAMP has also proved to be effective in maintaining meiotic arrest. For 
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example, the broad spectrum PDE inhibitor (IBMX) as well as PDE3A-specific 
inhibitors (milrinone and cilostamide) have been shown to increase cAMP levels 
within the oocyte and prolong the duration of meiotic arrest in cultured bovine and rat 
oocytes (Tsafriri et al., 1996; Thomas et al., 2002).  
It is hypothesised that the cAMP present in mammalian oocytes is synthesised by 
the oocyte itself and/or by the cumulus cells. The predominance of either oocyte-
derived or cumulus cell-derived intra-oocyte cAMP may be species-specific. In the 
first instance, varying amounts of cAMP can be produced in the oocyte itself in some 
species by the constitutive activity of a G-protein coupled receptor which activates an 
adenylyl cyclase. In the second instance, cAMP is produced in the cumulus and 
granulosa cell compartments of the follicle and is supplied to the oocyte through gap 
junctions (Mehlmann et al., 2002; Thomas et al., 2004; Gilchrist, 2011).  
The majority of studies that have investigated the origins of cAMP have utilised 
specific phosphodiesterase inhibitors and have indicated that the cumulus cells are 
responsible for the production of the majority of the intra-oocyte cAMP (Thomas et 
al., 2002). A recent study using a cAMP fluorosensor has indicated that FSH 
stimulation results in the accumulation of cAMP in the cumulus cells and 
subsequently in the oocyte (Webb et al., 2002). In addition, the loss of gap junctional 
communication resulting in the cessation of cAMP transfer into the oocyte caused 
meiotic resumption in rat COCs (Sela-Abramovich et al., 2006). However, cAMP 
transfer from the cumulus cells into the oocyte alone is not sufficient to maintain 
meiotic arrest in mouse oocytes suggesting a major role of oocyte-derived cAMP in 
this rodent species (Vaccari et al., 2008). This indicates that the importance of 
somatic cell-derived cAMP and intra-oocyte cAMP concentrations in maintaining 
meiotic arrest is likely to be species-specific.  
A number of studies supporting the importance of oocyte-derived cAMP in mice have 
shown that endogenous production of cAMP by adenylyl cyclases in the oocyte is 
sufficient to maintain meiotic arrest (Zhang and Xia, 2011). The production of cAMP 
by oocytes has been linked to Gs activation in rodent and human models and 
neutralization of Gs activity in mouse COCs by antibodies and RNA interference 
caused a decrease in cAMP levels and subsequent resumption of meiosis 
(Mehlmann et al., 2002; Hinckley et al., 2005; DiLuigi et al., 2008; Vaccari et al., 
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2008). G-protein coupled receptor 3 (GPR3) and G-protein coupled receptor 12 
(GPR12) have been identified as the predominant GPCRs in rodent oocytes 
responsible for maintaining cAMP levels. Studies in bovine COCs using 
compartment-specific (i.e. oocyte or cumulus cell) phosphodiesterase inhibitors have 
also suggested that in the cow, the oocyte may be able to produce adequate 
amounts of cAMP to maintain meiotic arrest (Thomas et al., 2002). While substantial 
evidence indicates that mouse oocytes are able to produce sufficient cAMP to 
maintain meiotic arrest, this has not been conclusively determined in other species 
like the rat, humans and cows.  
1.3.2. Cyclic GMP 
Cyclic GMP is produced in the somatic cells of the follicle and passes through gap 
junctions to the oocyte where it inhibits the hydrolysis of cAMP by PDE3A. It does 
this by binding to PDE3A at the same catalytic site as cAMP, but it is hydrolysed by 
PDE3A at a much slower rate, thus reducing the rate of cAMP hydrolysis thereby 
maintaining high levels of cAMP and meiotic arrest (Vaccari et al., 2009; Conti, 
2011). The inhibitory effect of cGMP on PDE3A is thought to have a major role in the 
maintenance of meiotic arrest in ovarian follicles. Moreover, like cAMP, cGMP levels 
decrease at the same time as spontaneous GVBD in rat oocytes in vitro (Törnell et 
al., 1990). It is currently accepted that both a decrease in gap junction permeability 
and decreased cyclic nucleotide production results in decreased oocyte cGMP levels 
(Robinson et al., 2012). In agreement with this theory, increasing follicular cGMP 
concentrations in whole pre-ovulatory follicles using two known inhibitors of a 
somatic cell-derived PDE5 (a known cGMP-specific phosphodiesterase) has been 
shown to increase the duration of meiotic arrest of oocytes in culture (Vaccari et al., 
2009). Likewise, inhibiting soluble guanylyl cyclase activity in rat COCs in vitro 
resulted in meiotic resumption and this effect could be ameliorated by co-treatment 
with a cGMP analogue (Sela-Abramovich et al., 2008) 
The addition of LH to whole follicles in culture decreased cGMP levels in somatic 
cells in vitro, leading to subsequent decreases in the level of intra-oocyte cGMP and 
the resumption of meiosis (Norris et al., 2009). The action of LH on reducing cGMP 
levels has recently been reported to be facilitated by the down-regulation of NPR2 
(the major guanylyl cyclase linked receptor in rodent ovarian follicles) as opposed to 
phosphodiesterase-mediated cGMP hydrolysis (Vaccari et al., 2009; Robinson et al., 
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2012).These events are thought to reflect that which occurs in the follicle in vivo as a 
result of the pre-ovulatory LH surge. This reinforces the importance of cGMP-
mediated PDE3A inhibition as an integral regulatory factor in the maintenance of 
meiotic arrest and that breakdown or down-regulation of cGMP production may lead 
to the resumption of meiosis.  
1.3.3. Phosphodiesterases and the Regulation of Follicular Cyclic 
Nucleotide Levels 
In addition to synthesising cyclic nucleotides, there are mechanisms of cyclic 
nucleotide degradation in ovarian follicles. Within the superfamily of cyclic nucleotide 
phosphodiesterases (PDE) there are 11 families, all of which convert cyclic 
nucleotides into inactive forms. The PDE isoforms 3 and 4 are known to hydrolyse 
the majority of cAMP in most cell types in the body. In the rat ovary, PDE3A has 
been identified in the oocyte while PDE4B and PDE4D have been identified as 
potentially two of the predominant isoforms present in somatic cells. It is the 
combination of these isoforms that are thought to be responsible for the hydrolysis of 
cAMP in the rat COC (Tsafriri et al., 1996; Richard et al., 2001; Francis et al., 2011). 
Using in situ hybridisation, PDE4D was shown to be specifically localised to the 
mural granulosa cells in rats and this signal increased as the maturational stage of 
follicles increased, whilst PDE4B was localised to the thecal and interstitial cells 
(Tsafriri et al., 1996). 
In rat oocytes, PDE3A activity was evident prior to spontaneous and gonadotropin-
induced oocyte maturation indicating that PDE3A activity is tightly regulated by the 
influence of inhibitory factors or stimuli (Richard et al., 2001). Additionally, the study 
of Pde3a-/-mice has been instrumental in understanding the action of PDE3A and its 
importance in maintaining meiotic arrest in mammalian oocytes. The Pde3a-/- mice 
were infertile and oocytes from these mice were meiotically incompetent as cAMP 
levels remained high even after the LH surge, thus preventing meiotic resumption 
(Shen et al., 2010). Interestingly the loss of an upstream receptor, GPR3, which is 
critical for cAMP signal transduction in oocytes (Gpr3-/- oocytes) ameliorated the 
overwhelming effect of the loss of PDE3A activity allowing cAMP levels to decrease 
to levels that permitted re-entry into meiosis (Vaccari et al., 2008). While these 
models demonstrate the importance of PDE3A, regulation of PDE3A activity within 
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the follicle is still poorly understood. Whilst PDE3A activity has been reported to be 
suppressed by high cGMP levels (Vaccari et al., 2009), there is some evidence that 
it is also regulated by phosphorylation (Francis et al., 2011).  
Additionally, isoforms of PDE4 in the follicle have been shown to be regulated by LH 
and FSH and thus are thought to be physiologically relevant to the regulation of 
meiotic arrest (Park et al., 2003). Knockout mice have also proven informative for 
understanding PDE4D function in the follicle. Pde4d-/- mice displayed impaired 
fertility with an inability to complete the latter stages of follicular maturation (Park et 
al., 2003; Conti, 2011). As discussed previously, regulation of cyclic nucleotide levels 
through both production and breakdown of cyclic nucleotides is used as a sensor in 
many systems in the body. The PDE4 family is often a target for the regulation of 
cAMP as it is known to be regulated by phosphorylation and changes in mRNA 
levels (Park et al., 2003).  
Similar to cAMP, specific mechanisms of cGMP degradation exist and can be 
manipulated to gain a better understanding of the importance of cGMP levels on 
meiotic arrest. For example, an injection of the catalytic domain of a cGMP-specific 
phosphodiesterase (PDE9A) resulted in the resumption of meiosis in follicular-
enclosed mouse oocytes (Norris et al., 2009). This would also indicate that the 
maintenance of high cGMP levels is also a requirement for the maintenance of 
meiotic arrest. 
1.4. Follicular-secreted Factors involved in the Maintenance 
of Meiotic Arrest in vitro 
The regulation of meiotic arrest is complex and in some species that have been 
studied, increasing intra-oocyte cAMP levels in isolation is not sufficient to maintain 
meiotic arrest in oocytes. This is the case in bovine oocytes, where meiotic 
resumption could only prevented by co-culture with 8-bromo cAMP and granulosa 
cells (Aktas et al., 2003). Furthermore, this study also found that culture of COCs 
with the somatic cells from the follicle increased developmental competence. As 
such, since the initial observation suggesting that the somatic cells, in particular the 
granulosa cells, of the follicle produce a meiosis-inhibiting substance (Pincus and 
Enzmann, 1935), a number of potential candidates have been identified. These 
include hypoxanthine (Eppig et al., 1985), the oocyte maturation inhibitor (Tsafriri 
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and Channing, 1975), nitric oxide (Nakamura et al., 2002) and more recently, C-type 
natriuretic peptide (Zhang et al., 2010). The commonality between all of these factors 
is that they all directly and indirectly have the ability to modulate intra-follicular cGMP 
pathways.  
1.4.1. C-Type Natriuretic Peptide (CNP) and Natriuretic Peptide 
Receptor 2 (NPR2) 
The natriuretic peptide family of proteins, which includes atrial natriuretic peptide 
(ANP) and brain natriuretic peptide (BNP), consists of small peptides containing a 
characteristic 17-member ring structure (Sellitti et al., 2011). There are lower 
circulating levels of CNP indicating that CNP acts in a paracrine manner as opposed 
to ANP and BNP which have much higher circulating levels and are known to have 
endocrine functions, namely in maintaining fluid homeostasis. CNP is linked to a 
number of unique functions such as endochondral ossification, nervous system 
function, development and health of the cardiovascular system through the 
regulation of smooth muscle and endothelial function as well as reproductive 
functions (Gutkowska et al., 1999; Sellitti et al., 2011; Kiyosu et al., 2012; Sato et al., 
2012). In female mice and pigs, CNP is involved in the maintenance of meiotic arrest 
(Zhang et al., 2010; Hiradate et al., 2013) and there is growing evidence that it is 
also involved in transduction of gonadotropin signalling involved in the transition from 
primary to pre-antral secondary follicles (Robinson et al., 2012; Sato et al., 2012). 
NPR2 (also known as NPR-B or guanylyl cyclase-B) is the high affinity receptor for 
CNP (Kiyosu et al., 2012), while ANP and BNP both act on natriuretic peptide 
receptor 1/guanylyl cyclase A (NPR1/NPR-A/GC-A) (Koller et al., 1991). The NPR2 
protein is made up of an extracellular ligand-binding domain and an intracellular 
homology domain which contains dimerization and catalytic domains (Abbey-Hosch 
et al., 2005). Transcriptome analysis of mouse cumulus cells showed a high level of 
expression of Npr2 (Zhang et al., 2010).  
The granulosa cells produce CNP which is released into the follicular fluid of the 
antrum and can subsequently bind to and activate NPR2 expressed on cumulus cells 
(and to a lesser extent, on the granulosa cells) (Zhang et al., 2010). Activation of 
NPR2 by CNP stimulates guanylyl cyclase activity resulting in the production of 
cGMP. Oocytes do not produce the requisite levels of cGMP, thus activation of 
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NPR2 is involved in the maintenance of meiotic arrest as a result the production and 
subsequent trafficking of cGMP through gap junctions into the oocyte (Zhang et al., 
2011). 
Interestingly, expression levels of Npr2 mRNA are up-regulated by OSFs like 
BMP15, GDF9 and fibroblast growth factor 8B (FGF8B) as well as steroid hormones, 
namely oestradiol and testosterone (Zhang et al., 2010, 2011). It is unclear whether 
OSFs are able to promote sufficient Npr2 expression to maintain meiotic arrest but 
OSFs have been implicated in increasing oestradiol production in granulosa cells 
and this could contribute to the maintenance of meiotic arrest (Vanderhyden et al., 
1993; Brankin et al., 2003; Lucidi et al., 2003). Furthermore, Nppc (the gene 
encoding CNP) and Npr2 mRNA expression are modulated during the oestrous cycle 
and indicate a role for CNP/NPR2 signalling in female fertility in the rat (Jankowski et 
al., 1997; Gutkowska et al., 1999). Treatment of mouse ovaries with LH (mimicking 
the pre-ovulatory LH surge) decreased the expression of Nppc mRNA in the 
granulosa cells. Similarly, measurement of CNP protein concentrations in human 
follicular fluid showed that pre-treatment with hCG resulted in a reduction in 
secretion of CNP (Kawamura et al., 2011). Accordingly, this suggests that CNP is 
involved in the maintenance of meiotic arrest in vivo and that stimulation with LH (or 
hCG) results in a decrease in CNP and subsequently a decrease in cGMP (Tsuji et 
al., 2012). 
Furthermore, administration of CNP to mouse and pig COCs cultured in vitro 
reduced the proportion of oocytes undergoing spontaneous GVBD in a dose-
dependent manner (Zhang et al., 2010; Kawamura et al., 2011; Hiradate et al., 
2013). There is strong evidence from mouse models with mutations in Nppc and 
Npr2 that CNP/NPR2 signalling is required for the maintenance of meiotic arrest 
(Kiyosu et al., 2012; Geister et al., 2013). Thus CNP and its receptor NPR2 are 
involved in the maintenance of meiotic arrest through increased production of cGMP 
and indirect modulation of intra-oocyte cAMP concentrations. 
1.4.2. The Role of Steroid Hormones in CNP/NPR2 Signalling 
Androgens, oestrogens and progestins are synthesised by the developing follicle at 
various stages of development. The synthesis and levels of each of these steroid 
hormones is dependent on the stage of follicular development and external signals 
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received, including gonadotropin signalling. Follicular fluid contains high steroid 
hormone concentrations with particularly high concentrations of testosterone and 
comparatively lower concentrations of progesterone and oestradiol (Goff and 
Henderson, 1979; McNatty et al., 1986; Westergaard et al., 1986; Kaji et al., 1987).  
Progestins have been shown to be important for the process of folliculogenesis and 
in particular, the process of ovulation. Progesterone receptor null mice are infertile, 
due to the inability to ovulate under normal gonadotropin stimulation or gonadotropin 
hyper-stimulation (Lydon et al., 1995). Immunohistochemical studies have localised 
progesterone receptors to the theca of small antral follicles and the granulosa cells of 
pre-ovulatory follicles following hCG stimulation in both the rat and monkey (Hild-
Petito et al., 1988; Park and Mayo, 1991). 
The role of androgens in follicular development is still not fully understood. The 
androgen receptor has been shown to be most highly expressed in small pre-antral 
and early antral follicles and it is possible that it has an essential role in the early 
stages of follicular development (Pelletier et al., 2000). Conversely, it has also been 
postulated that the most important role for androgens is as a substrate for P450 
aromatase in order to produce oestradiol (Drummond, 2006). 
Oestradiol is produced by the granulosa cells of the ovary (Yang and Fortune, 2008; 
Zhang et al., 2011). It has a range of functions in female mammals including, 
regulation of the oestrous cycle, sexual differentiation and a central role in follicular 
development. Oestradiol is first produced in appreciative amounts in follicles during 
the latter stages of follicular development and it is in pre-ovulatory follicles that 
oestradiol production is at its highest due to the large number of granulosa cells. 
Oestradiol has been shown to induce expression of FSH, LH and prolactin receptors. 
Additionally, oestradiol has been shown to modulate cAMP signalling and this effect 
is regulated by the gonadotropins (Richards and Rolfes, 1980). 
Initial experimental evidence suggested that testosterone and progesterone were 
more potent than oestradiol at inhibiting GVBD when administered in combination 
with dbcAMP (Kaji et al., 1987). However, the inhibitory effects of progesterone and 
testosterone may, at least in part, be attributed to their action as substrates for 
oestradiol production as it has been reported that granulosa cells aromatise 
testosterone to oestradiol when stimulated by cAMP (Vanderhyden et al., 1993).  
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The potential role of oestradiol in regulating cumulus cell functions is further 
supported by reports of increased Npr2 expression in cumulus cells of mouse COCs 
cultured with exogenous oestradiol in vitro (Zhang et al., 2011) and of impaired 
cumulus cell expansion in Esr2 (oestrogen receptor β)-deficient mice (Couse et al., 
2005). Together these results imply that oestradiol is another major follicular factor 
that may regulate the maintenance of meiotic arrest through modulation of NPR2 
expression levels and subsequent cGMP concentrations. 
1.4.3. The Role of CNP/NPR2 Signalling in the Maintenance of 
Meiotic Arrest in Mice 
The majority of work investigating the effects of the CNP/NPR2 regulatory pathway 
on the maintenance of meiotic arrest has been undertaken in mice (Zhang et al., 
2010, 2011). This work has culminated in the development of a hypothetical model 
that illustrates the mechanism of action through which CNP may regulate meiotic 
arrest and how this pathway may be further modulated by oestradiol (Figure 1-5). 
1.5. Species Differences in the Regulation of Meiotic Arrest 
Mice and rats are the commonly used model organisms for research involving 
female reproduction in mammals. Whilst this literature review has presented a 
hypothetical model for the regulation of meiotic arrest in mice, it is important to note 
that recent evidence reveals significant discrepancies in the regulation of meiotic 
arrest between these two rodent species.  
The first such discrepancy is that there is extensive evidence that mouse oocytes 
have the ability to produce sufficient cAMP to maintain meiotic arrest from localised 
adenylyl cyclases in the oocyte membrane (Hinckley et al., 2005; Mehlmann, 2005b). 
While oocyte-derived adenylyl cyclases have been identified in the rat, the ability to 
produce sufficient cAMP to maintain meiotic arrest has not been fully substantiated. 
Furthermore, modulation of cAMP levels using cAMP analogues and PDE inhibitors 
was shown to maintain meiotic arrest in rat oocytes but this approach was much less 
effective when compared to mouse oocyte (Downs, 2011). Additionally, in contrast to 
the mouse, administration of a cGMP analogue (8-Br-cGMP) to cultured rat COCs 
did not result in the maintenance of meiotic arrest (Downs, 2011).  
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Figure 1-5: The hypothesised regulatory mechanism for meiotic arrest in the mouse. Panel A 
illustrates the action of CNP on its cognate receptor NPR2, which results in increased cGMP 
production and subsequently cGMP levels in the cumulus cells. The cGMP is transferred via 
gap junctions from the cumulus cells into the oocyte where it reduces the rate of cAMP 
hydrolysis by PDE3A. This results in high levels of cAMP and thus, maintains meiotic arrest in 
the oocyte. Oestradiol produced by the granulosa cells upregulates Npr2 expression in the 
cumulus cells, further propagating the effects of CNP described above. Furthermore, FSH has 
been shown to increase Nppc expression in the granulosa cells resulting in an increase in 
CNP synthesis. Panel B indicates that LH has been shown to decrease Nppc expression 
resulting in a decrease in CNP synthesis. In addition, decreased activation of NPR2 (through 
reduced CNP levels) decreases cGMP levels in the cumulus cells. This results in increased 
PDE3A hydrolysis of cAMP and lowered levels of cAMP in the oocyte culminating in the 
resumption on meiosis.  
A. 
B. 
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Despite these significant species-specific differences, there is evidence that the 
hypothesised mechanism may also be relevant in rats. Both of the genes encoding 
for CNP and NPR2 (Nppc and Npr2, respectively) are highly expressed in the rat 
ovary and their expression levels are influenced by the stage of the oestrous cycle 
(Jankowski et al., 1997; Gutkowska et al., 1999; Noubani et al., 2000). This would 
indicate that a unique regulatory mechanism involving the CNP pathway may exist in 
rats in regards to the maintenance of high intra-oocyte cAMP levels and 
subsequently maintenance of meiotic arrest.  
1.6. The Overall Objectives and Aims 
The overall objective of this study was to test the validity of the hypothesised model 
illustrated in Figure 1-5 in maintaining meiotic arrest in rat oocytes. The effects of 
CNP and oestradiol alone or in combination were tested on rat COCs that were 
cultured in vitro for different lengths of time. With reference to this hypothesised 
model, this study sought to determine the effects of these treatments on four 
different aspects of the model pathway following both short and long incubation 
periods. 
The first aim of this study was to assess the effects of CNP and oestradiol on gap 
junction permeability within rat COCs using an optimised gap junction assay. This 
aim tested the feasibility of the hypothesised model in terms of whether the rate of 
transfer of cAMP and cGMP from the cumulus cells to the oocyte via gap junctions 
could be modulated by these treatments.  
The second aim was to measure the effects of CNP and oestradiol on cGMP levels 
within rat COCs. These experiments were designed to confirm previous reports that 
these treatments increased cGMP levels within mouse COCs (Zhang et al., 2010, 
2011).  
The third aim was to assess the effects of CNP and oestradiol on mRNA expression 
levels of key cumulus cell-derived genes involved in the hypothesised pathway. The 
key candidate genes were Npr2, Pde4b and Pde4d. This aim sought to elucidate the 
validity of previous observations that oestradiol modulates Npr2 expression levels in 
the mouse and rat (Noubani et al., 2000; Zhang et al., 2011) as well as address the 
lack of knowledge on the predominant forms of phosphodiesterases within rat 
cumulus cells.  
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The fourth aim was to assess the effects of CNP and oestradiol on the duration of 
meiotic arrest in rat COCs that were cultured in vitro by assessing the timing of 
initiation of GVBD in treated and control COCs. This aim sought to verify the action 
of these potential regulatory agents on the maintenance of meiotic arrest in rat COCs 
using the optimised culture conditions described in this study.
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Chapter 2: Materials and Methods 
2.1. Chemicals, Stock Solutions and Media 
The dissection media was comprised of Leibovitz L-15 (Cat. No. 11415-064, Life 
Technologies, Carlsbad, California, USA) supplemented with 0.1 % BSA, 100 IU/mL 
Penstrep (10,000 units penicillin and 10,000 µg streptomycin) (Cat. No. 151140122, 
Life Technologies) and 15 mM Hepes buffer (Cat. No. H4034, Sigma-Aldrich, 
Auckland, NZ). 
The wash media was comprised of phenol-red free M199 (Cat. No. 11043-02, Life 
Technologies) supplemented with 0.1 % BSA and 100 IU/mL Penstrep. 
The incubation media was comprised of phenol-red free M199 supplemented with 
0.3 mg/mL polyvinyl alcohol (PVA; Cat No. P8136, Sigma-Aldrich). 
Stock solutions of 10 mM dipyradimole and 10 mM rolipram (Cat. No. D9766 and 
R6520, respectively, Sigma-Aldrich) were made up in dimethyl sulfoxide (DMSO; 
Cat. No. 41639, Sigma-Aldrich). These solutions were then mixed at a 1:1 ratio and 
stored at -20 ˚C. Unless otherwise indicated, a phosphodiesterase inhibitor solution 
containing 5 mM dipyradimole and 5 mM rolipram was supplemented to all media to 
reach a final concentration of 50 µM for both dipyradimole and rolipram. 
C-Type Natriuretic Peptide (CNP; Cat. No. N8768, Sigma-Aldrich) was resuspended 
in dH2O to produce a 5 µM stock solution. This solution was aliquoted and stored 
at -20 ˚C. 
The steroid hormones used in this study were oestradiol (E2; Cat. No. E8875, Sigma-
Aldrich) and progesterone (P4; Cat. No. P0130, Sigma-Aldrich). Both steroid 
hormones were dissolved in absolute ethanol (Cat. No. ET0016, Scharlau Chemie, 
Australia) to a stock solution concentration of 5 mg/mL.  
Calcein acetoxymethyl (AM) vials (Cat. No. C3100MP, Life Technologies) were 
reconstituted with DMSO to result in a 1 mM stock solution. Aliquots of the 
calcein-AM stock solution were stored at -20 ˚C, and were discarded if not used 
within one month of reconstitution. Calcein is a green fluorescent indicator with an 
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excitation wavelength of 495 nm and an emission wavelength of 515 nm (Life 
Technologies, 2010). 
The fixative used in the orcein staining experiments was comprised of 3:1 ethanol to 
acetic acid. 
The orcein stain solution was made by dissolving 0.5 g of orcein powder (Cat. No. 
75410, Sigma-Aldrich) in 22.5 mL of dH2O while heating and stirring gently for 
one hour. Following this, a further 27.5 mL of dH2O was added to result in a final 
concentration of 1 % w/v orcein and the stain was filtered twice using a Whatman 
No.1 filter. 
The de-staining solution used in the orcein staining experiments was comprised of 
3:1:1 of ethanol: acetic acid: glycerol (Cat. No. G5516, Sigma-Aldrich). 
2.2. Animals and Tissue Collection 
The animals sourced for this study were excess to the requirements of breeding 
programmes undertaken in the School of Psychology and the School of Biological 
Sciences at Victoria University of Wellington (VUW). While ethical approval was not 
required for this study, the number of animals used was recorded and provided to 
the VUW Animal Ethics Committee for annual reporting purposes. Sexually immature 
(21-25 day old) female Sprague-Dawley rats were euthanized by carbon dioxide 
(CO2) asphyxiation and the ovaries were dissected into dissection media. Each 
ovary was kept in a water-bath at 37 ˚C until dissected.  
The ovaries were transferred to a petri dish containing dissection media and trimmed 
of excess fat under a Leica M80 dissecting microscope (Wetzlar, Germany). The 
ovaries were then transferred to a new petri dish containing fresh dissection media 
and each visible follicle was punctured with a 20-gauge needle to liberate the COC 
from the follicle. The COCs were then transferred to another petri dish containing 
dissection media. This pool of COCs was then used to select ‘healthy’ COCs (i.e. 
COCs with two or more intact layers of cumulus cells surrounding an oocyte) for use 
in subsequent experiments. 
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2.3. Experimental Design 
This study was designed to investigate the effects of CNP and oestradiol alone or in 
combination on COCs in regards to (i) gap junction activity between the cumulus 
cells and the oocyte, (ii) cGMP concentrations in COCs, (iii) gene expression levels 
of key genes involved in intracellular cGMP signalling (Npr2, Pde4b, Pde4d) and, (iv) 
the proportions of oocytes that undergo GVBD. To mitigate the spontaneous 
resumption of meiosis that occurs upon extraction of the COC from the ovarian 
follicle, the majority of these in vitro experiments were performed under maintenance 
of meiotic arrest (i.e. with addition of the phosphodiesterase inhibitors dipyradimole 
and rolipram). Several experiments were undertaken to optimise the in vitro 
conditions required for this study. Thereafter, experiments were performed using a 
general treatment protocol that was modified to accommodate the different 
experimental aims. 
For each replicate experiment, a range of 15 to 20 COCs were selected from the 
‘healthy’ COC pool for each treatment group at each time point. The general 
treatment protocol involved these COCs being transferred through two wash steps in 
wash media before being transferred to wells of a 48-well plate containing incubation 
media supplemented with the relevant treatments. The duration of incubation was 
dependent upon the experiment and will be discussed in subsequent sections. Upon 
completion of the incubation period, individual oocytes were stripped of their cumulus 
cells. Oocytes were either processed for gap junction activity by measurement of 
fluorescence and/or GVBD assessment and cumulus cells were processed for 
qPCR. In regards to the experiments in which cGMP levels were directly measured, 
whole COCs were used. 
2.4. Gap Junction Assay 
The gap junction assay utilised an acetoxymethyl derivative of calcein (calcein-AM) 
as a fluorescent dye marker of substrate movement from cumulus cells into the 
oocyte. Calcein-AM is colourless and non-fluorescent due to the addition of the AM 
ester group which results in an uncharged molecule that can permeate cell 
membranes. Calcein-AM was added to the wells containing the COCs following their 
incubations in appropriate treatments for the appropriate predetermined incubation 
time. In the context of the gap junction assay, calcein-AM enters the cumulus cells 
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and once intracellularly-located, is hydrolysed resulting in the production of calcein. 
A further one hour incubation time of the treated COCs allowed for the transfer of the 
fluorescent dye from the cumulus cells into the oocyte via gap junctions. Following 
the stripping of cumulus cells from the oocyte, the fluorescence level in the individual 
denuded oocytes was an indirect measure of gap junction communication within the 
COCs. The gap junction assay protocol that was used in this study had previously 
been optimised and validated for use in the rat (Campen, 2013). 
The COCs used in the gap junction assays were collected as described in Section 
2.2 and 2.3. All incubations were carried out at 37 ˚C with 5 % CO2 and 96 % 
humidity. For the optimisation experiment, the COCs were incubated in incubation 
media supplemented with either phosphodiesterase inhibitors or DMSO (control) for 
either 0, 4 or 18 hours. In the subsequent gap junction assay experiments, all media 
was supplemented with phosphodiesterase inhibitors and incubation media was 
further supplemented with either ethanol (control), CNP (100 nM), oestradiol 
(200 ng/mL), CNP (100 nM) and oestradiol (200 ng/mL) in combination, or CNP 
(100 nM) and progesterone (200 ng/mL) in combination for 0, 4 or 18 hours. At the 
completion of the incubation period, all COCs were then transferred into incubation 
media supplemented with the appropriate treatments as described above and 
calcein-AM (at a final concentration of 2 µM) and incubated for a further 10 minutes. 
The COCs were then transferred to the final one hour incubation in incubation media 
supplemented with the appropriate treatments. As a result, COCs were incubated 
with the treatments for a total of approximately 1, 5 or 19 hours. 
At the end of the final incubation, the COCs were transferred to a 96-well plate 
(Thermo Fisher Scientific, Auckland, NZ) where single COCs were transferred 
through two washes in phosphate buffered saline (PBS; Cat. No. P4417. Sigma-
Aldrich) and then into a well containing 10 µL of PBS. The cumulus cells were 
stripped of the oocytes by vigorous pipetting to result in a denuded oocyte (DO) and 
a number of cumulus cells. The DOs were then transferred to a separate 96-well 
plate containing PBS and the plate containing the cumulus cells was sealed and 
stored at -80 ˚C for qPCR analysis. The DOs were photographed to assess whether 
a GV was present (Figure 1-3). If no GV was observed, oocytes were noted as 
having initiated GVBD. The fluorescence intensity in all DOs was measured using a 
Leica inverted microscope (CTR4000) with a CRAIC fluorescence detection system 
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(Leica Microsystems; Wetzlar, Germany). The measurements were captured over 
50 milliseconds in the wavelength range of 300 to 700 nm. 
2.5. cGMP Assay 
COCs were collected as described previously and for each replicate experiment, 100 
COCs were selected from the ‘healthy’ COC pool for each treatment group. 
Phosphodiesterase inhibitors were not supplemented to any of the media in this 
experiment. The COCs were transferred through two wash steps in wash media 
before being transferred to wells of a 48-well plate containing incubation media 
supplemented with the relevant treatments. The treatments that were used for the 
cGMP assays were incubation media supplemented with ethanol (control), CNP 
(100 nM), oestradiol (200 ng/mL) or CNP (100 nM) and oestradiol (200 ng/mL) in 
combination. COCs were incubated with each of the treatments for 5 hours. 
At the end of the incubation period, COCs from each of the treatment groups were 
pooled into a microcentrifuge tube and centrifuged for 10 minutes at 800 × g. The 
excess media was removed and 10 µL of 0.1 M HCl was added to each tube and 
vortexed briefly. The tubes were then incubated on ice for five minutes before being 
stored at -80 ˚C until further processing. 
The measurement of cGMP concentrations within pools of 100 COCs was carried 
out using the reagents provided by the cGMP Direct Immunoassay Kit (Cat. No. 
ab65356, Abcam, Cambridge, UK) following a modification of the manufacturer’s 
instructions. In detail, a 2 pmol/µL cGMP working solution was prepared for the 
standard curve by diluting the 10 pmol/µL cGMP standard stock solution in 0.1 M 
HCl. This was subsequently diluted in 0.1 M HCl to produce a standard curve 
incorporating 0.039, 0.078, 0.156, 0.3125, 0.625, 1.25, 2.5, 5 and 10 pmol/50 µL 
standards. To 10 µL of each standard or sample, an aliquot of 5 µL of neutralising 
buffer was added to neutralize the HCl. Thereafter, both standards and samples 
were acetylated with 5 µL of the acetylating reagent mix, vortexed for three seconds, 
and the acetylation mix was evaporated by incubation at room temperature for 
10 minutes. Finally, 90 µL of assay buffer was added to result in a final 
standard/sample volume of 110 µL and the tubes mixed well.  
To each Protein G coated well, 50 µL of each of the samples and standards were 
added in duplicate. Thereafter, 10 µL of cGMP antibody was added per well and the 
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plate was incubated for one hour at room temperature with gentle agitation. A 10 µL 
aliquot of cGMP-HRP was added and the samples were incubated at room 
temperature for a further one hour with gentle agitation. The plate was washed five 
times with the 1× assay buffer and then 100 µL of HRP developer was added to 
each well. The plate was incubated for a further hour at room temperature under 
gentle agitation. Finally, the reaction was stopped by adding 100 µL of 1 M HCl. 
The AbCAM cGMP Direct Imunnoassay Kit has a detection range of 0.04 - 
10 pmol/50 µL (i.e. per well). The absorbance of each of the wells at 450 nm was 
measured using a VICTOR3 multilabel plate reader (Perkin Elmer, Waltham, MA, 
USA). A control sample containing 100 COC was included in each of the replicates, 
in order to account for variance between replicates.  
2.6. Quantitative PCR (qPCR) 
In order to optimise a TaqMan quadriplex qPCR reaction, pools of 50 COCs were 
used to produce template cDNA. The COCs were extracted from the ovaries as 
described in Section 2.2. Healthy COCs were selected and then washed twice in 
PBS before being collected into a microcentrifuge tube and centrifuged at 800 × g for 
10 minutes. Excess PBS was removed and the pellet containing intact COCs was 
stored at -80 ˚C until subsequent RNA extraction. 
The experimental samples contained only the cumulus cells that were collected from 
individual COCs used in the gap junction assay experiments. It is important to note 
that each sample contained cumulus cells from one individual COC. Briefly, the 
treatment groups included COCs incubated in media supplemented with either 
ethanol (control), CNP (100 nM), oestradiol (200 ng/mL), CNP (100 nM) and 
oestradiol (200 ng/mL) in combination, or CNP (100 nM) and progesterone 
(200 ng/mL) in combination for a total of 1, 5 or 19 hours. For each of the five 
experimental replicates, three out of the 8-10 COCs that were exposed to each 
treatment regime at each time point, were randomly selected for qPCR analyses. 
Consequently for each treatment group at each time point, a total of 11 -15 individual 
cumulus cells samples were used for qPCR analyses. The CC’s were stored 
at -80 ˚C until RNA extractions were performed.  
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2.6.1. RNA Extraction 
Extraction of total RNA was performed using the ArrayPureTM Nano-scale RNA 
Purification Kit (Cat. No. MSPS04050, Epicentre, Madison, WI, USA) following the 
manufacturer’s instructions. Briefly, a solution of 5 µg/µL Proteinase K diluted in 
Nano-Scale Lysis solution was prepared at a ratio of 1:30 (v/v) and then vortexed to 
mix. Because the samples had been collected for previous gap junction 
measurements, samples were stored in 96-well plates. Aliquots of 30 µL of the 
diluted Proteinase K solution was added to each frozen sample, mixed thoroughly by 
pipetting and then the entire sample was transferred into individual clean 
microcentrifuge tubes. 
The samples were incubated at ~68 ˚C for 15 minutes before being placed on ice for 
3-5 minutes. At this point, 18 µL of MPC protein precipitation reagent was added to 
each of the samples and mixed thoroughly by vortexing. Thereafter the resulting 
debris was pelleted by centrifugation at 13,400 × g at 4 ˚C for 7 minutes and the 
supernatant was then transferred into a clean 0.5 mL microcentrifuge tube. A 50 µL 
aliquot of RNase-free isopropanol (Cat. No. APPA39281000PE, Global Science, NZ) 
was added to the supernatant and vortexed. Subsequently, the RNA and 
contaminating DNA was pelleted by centrifugation at 13,400 × g at 4 ˚C for 5 minutes 
which allowed for the removal of the excess isopropanol and the pellet was air-dried 
for a further 5 minutes. Meanwhile, RNase-Free DNase I was diluted in DNase 
Buffer at a dilution factor of 1:40 (v/v). An aliquot of 20 µL of the DNase I solution 
was added to each of the samples to resuspend the nucleic acid pellet. The samples 
were then incubated at 37 ˚C for 30 minutes. At the end of the incubation period, 
20 µL of 2× Nano-scale Lysis solution was added to each sample and mixed well. 
After which, 20 µL of the MPC protein precipitating reagent was added and the 
samples were mixed before being placed on ice for 3-5 minutes. The samples were 
then centrifuged at 13,400 × g at 4 ˚C for 5 minutes to pellet the debris. The 
supernatant was carefully removed and transferred to a clean tube and 50 µL of 
RNase-free isopropanol was added to precipitate the RNA and the samples were 
mixed by vortexing. 
The purified RNA was pelleted by centrifugation at 13,400 × g at 4 ˚C for 5 minutes 
and excess isopranol was removed before the pellet was rinsed with 50 µL of 70 % 
ethanol (Cat. No. APPA39281000PE, Global Science). The samples were 
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centrifuged at 13,400 × g at 4 ˚C for 3 minutes and the excess ethanol was removed. 
The RNA pellet was air-dried for 5 minutes and then resuspended in 10 µL of 
ultrapure (U/P) dH2O (Cat. No. 10977, Life Technologies) by vortexing for two 
minutes and then briefly centrifuged. To assist the resuspension process, the RNA 
samples underwent a final incubation at 55-58 ˚C for 2 minutes before being 
vortexed and then stored at -80 ˚C. 
2.6.2. cDNA Synthesis 
Complimentary DNA (cDNA) was synthesised using the reagents supplied in the 
SuperScript® VILO™ cDNA Synthesis Kit (Cat. No. 11754-050, Life Technologies) 
following manufacturer’s instructions. A master-mix solution sufficient for 10 samples 
was prepared on ice that consisted of 40 µL of 5× VILO™ Reaction Mix, 40 µL of 
U/P dH2O and 20 µL of 10× SuperScript® Enzyme Mix .The entire 10 µL of RNA 
sample was added to a new tube followed by 10 µL of the master-mix solution. 
Following a brief vortex and centrifugation step, the samples were then placed in the 
Rotor-GeneTM 6000 Rotary 56 Analyzer (Model No. 11754-050, Corbett Life Science, 
Sydney, Australia) and incubated at 25 ˚C for 10 minutes followed by incubation at 
42 ˚C for 120 minutes. This reaction was terminated by an incubation step at 85 ˚C 
for 5 minutes. The resultant samples of cDNA were then stored at -20 ˚C. 
2.6.3. qPCR 
This study utilised two different qPCR methodologies for the determination of relative 
gene expression levels. For the optimisation steps, both the SYBR® Green and 
TaqMan methods were used. Determination of optimal primer concentrations was 
undertaken using SYBR Green chemistry while probe optimisation steps were 
performed using TaqMan chemistry. The forward and reverse oligonucleotide 
primers and probes for each of the target genes were designed using the Beacon 
Designer software package (Premier Biosoft International, USA) and these are listed 
in Table 2-1. 
Following successful optimisation of the qPCR protocol, the relative gene expression 
levels in all experimental cDNA samples were determined using an optimised 
TaqMan quadriplex qPCR methodology. 
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Table 2-1: NCBI Accession numbers and nucleotide sequences for the TaqMan probe and 
forward (F) and reverse (R) primers for the genes investigated in this study.  
Gene Accession 
Number 
TaqMan (Hydrolysis) Probe (5’ - 3’) Primers 
Pde4b NM_017031 [6FAM]CAGCGAACAACACGGCGATGA[BHQ1] 
F – CAAGGAACTCCTCACTTC 
R - GGGTGAAATTGTTTCTTACG 
Pde4d NM_001113332 [ROX]CCTCCTCTTCAACCTGCTCGTCA[BHQ2] 
F – GACAGTGGAAGTCAAGTG 
R – GGCTTTCCTCTTCTGCTA 
Npr2 NM_053838 [HEX]CAATGGTCACTGTGTCTCCACTTGA[BHQ1] 
F – GCTGTTGGTACTTGGATG 
R - CAGAGGGCTTATATGACTTC 
Rpl19 NM_031103 [CY5]CCAATGCCAACTCTCGTCAACAGAT[BHQ3] 
F – CCCAATGAAACCAACGAAA 
R – GGGAATGGACAGTCACAG 
 
2.6.3.1. Primer Optimisation 
The Brilliant II SYBR® Green QPCR Master Mix kit (Cat. No. 600828, Agilent 
Technologies, CA, USA) used in this study utilises the SYBR® Green I fluorescent 
dye which binds non-specifically to double-stranded (ds) DNA. As a result, in the 
denaturation step of the PCR cycle, there is little fluorescence as only single 
stranded DNA is present. Subsequently during the annealing step, the synthesis of 
ds DNA allows for binding of the SYBR® Green I dye resulting in increased 
fluorescence and this can be monitored in a linear fashion over a range of 
successive PCR cycles. The threshold cycle (Cq) is defined as the cycle at which the 
intensity of the fluorescent signal is significantly higher than the background 
fluorescence and is dependent on the initial concentration of the target gene in the 
sample (Agilent Technologies, 2009). 
Table 2-2: Final optimised forward and reverse primer and TaqMan probe concentrations (nM) 
that were used in the quadriplex qPCR reactions. 
Gene 
Primer (nM) 
TaqMan Probe (nM) 
Forward Reverse 
Pde4b 500 300 300 
Pde4d 200 200 100 
Npr2 100 200 200 
Rpl19 300 200 100 
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The reagents and protocols from the Brilliant® II SYBR® Green QPCR Master Mix 
kit were used for primer optimisation. In brief, after thawing the primers and cDNA 
samples, a master mix was made up for each of the primer sets to be tested. In 
order to determine the optimal forward and reverse primer concentrations, 
combinations of the forward and reverse primer concentrations were titrated between 
the concentration of 50 nM and 300 nM. Each gene was assessed individually and 
the combination of most dilute primer concentrations that resulted in the lowest Cq 
value was chosen as the optimised primer concentration (Table 2-2). For each 
different primer set concentration, a master-mix solution that contained 26 µL of 
2× SYBR Green Master Mix, forward and reverse primers and 1.04 to 3.12 µL of 
template cDNA was made up to 52 µL with U/P dH2O. After mixing, duplicate 
aliquots of 25 µL of the master mix containing cDNA were pipetted into 0.1 µL strip 
tubes. The PCR reaction was run on a Rotor-Gene™ 6000 Rotary 56 Analyzer 
(Corbett Research) under the following thermal conditions: one cycle at 95 ˚C for 
10 minutes, 40 cycles of 95 ˚C for 15 seconds and 60 ˚C for 60 seconds and a final 
melt step which involved heating the samples from 60 ˚C to 95 ˚C at 0.5 ˚C 
increments for 5 seconds each. 
2.6.3.2. Probe Optimisation and qPCR Sample Analysis 
For this study, a quadriplex TaqMan reaction was utilised that involved the 
measurement of genes thought to be involved in the modulation of intracellular levels 
of cGMP within rat cumulus cells, namely, phosphodiesterase 4B (Pde4b), 
phosphodiesterase 4D (Pde4d) and natriuretic peptide receptor 2 (Npr2). A 
previously validated reference gene, 60S ribosomal protein L19 (Rpl19), was used to 
correct for RNA input and all results are relative to the reference gene (Crawford and 
McNatty, 2012; Ekart et al., 2013). 
The sequence of the probes and the relevant fluorophores and quenchers that were 
used are listed in Table 2–1. The probes were designed such that the fluorophore 
(either 6FAM, ROX, HEX or Cy5) was located at the 5’ end of the sequence and the 
quencher was located at the 3’ end. This combination of fluorophore and quencher 
underpins the TaqMan chemistry. While the probe is annealed to the target 
sequence or unhybridised, no fluorescence is measured due to the proximity of the 
quencher to the fluorophore. Consequently, during the annealing-extension step, the 
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fluorophore and quencher are separated as a result of the DNA polymerase action. 
This results a measurable increase in fluorescence.  
The reagents and protocols from the Brilliant Multiplex QPCR Master Mix (Cat. No. 
600553, Agilent Technologies, CA, USA) were used for probe optimisation and for 
analysis of experimental samples. In order to determine the optimal probe 
concentrations, differing probe concentrations were titrated between 50 and 300 nM. 
For each probe concentration, a mastermix solution containing 26 µL of 2× Brilliant 
multiplex qPCR Master Mix, the probe, optimised forward and reverse primer 
concentrations, and 1.04 to 3.12 µL of template cDNA was prepared to a final 
volume of 52 L with U/P dH2O. Duplicate 25 L aliquots of master mix for each 
probe concentration were then added to strip tubes, capped and run on the Rotor-
Gene™ 6000 Rotary 56 Analyzer. The thermal cycling program described for 
SYBR® Green reactions was used with the exclusion of the final melt step. Optimal 
probe concentrations were determined as the lowest concentration that yielded the 
lowest Cq value for each gene without compromising the endpoint fluorescence. 
Optimised primer and probe concentrations (Table 2-2) were then used for 
subsequent gene expression analyses of experimental samples. 
All samples were run in duplicate and corrected for the total amount of cDNA present 
using Rpl19 as the reference gene. As a large number of samples were to be 
analysed, multiple reaction runs were undertaken, thus samples were also corrected 
to a calibrator sample that was present in every run. Therefore, the 2-ΔΔCT method 
was then employed to determine the fold-change in expression of the candidate 
genes (Livak and Schmittgen, 2001).  
2.6.3.3. Multiplex Optimisation 
Prior to assessing any of the experimental samples, the reaction efficiencies for each 
of the genes were assessed. A serial dilution of cDNA from a pool of 50 COCs was 
prepared (1:1 – 1:128) by diluting each of the successive dilutions in U/P dH2O. 
Using the TaqMan protocol and optimised primer and probe concentrations, the 
amplification efficiencies were calculated as shown in Table 2-3. Due to low gene 
abundancy, Pde4b expression analysis within the quadriplex reaction could not be 
fully optimised. 
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Table 2-3: The amplication efficiency for each of the genes in the multiplex qPCR reactions. 
Gene Efficiency (%) 
Pde4b - 
Pde4d 90 
Npr2 93 
Rpl19 98 
 
2.7. Assessment of GVBD and Orcein Staining 
The initiation of GVBD was assessed under a Leica inverted microscope by 
visualising the presence or absence of a GV in all COCs that were used in the gap 
junction assay as described in Section 2.4. As such, all of the treatment groups were 
the same. In detail, all media was supplemented with the phosphodiesterase 
inhibitors and either ethanol (control), CNP (100 nM), oestradiol (200 ng/mL), 
CNP (100 nM) and oestradiol (200 ng/mL) in combination, or CNP (100 nM) and 
progesterone (200 ng/mL) in combination, for a total of 1, 5 or 19 hours.  
A subsequent experiment was performed in order to better assess differences in the 
timing of meiotic resumption due to the exposure of COC to a combination of CNP 
and oestradiol using an orcein staining method to clearly identify meiotic stages. For 
each of the treatment groups, 12-15 COCs were collected and cultured as previously 
described (Sections 2.2 and 2.3). To enable the unrestricted resumption of meiosis 
in the cultured COCs, the PDE inhibitor solution was not used in these experiments. 
COCs were incubated in incubation media supplemented with either ethanol (control) 
or CNP (100 nM) and oestradiol (200 ng/mL) in combination for 5 hours. A no-
incubation control was also collected and this served as a 0 hour (no treatment, no 
incubation time) control. The COCs were transferred through two washes in PBS. 
The oocytes were then denuded from the attached cumulus cells by vigorous 
pipetting in PBS. Denuded oocytes were then assessed for the presence or absence 
of the GV by observation using the Leica inverted microscope and photographed. 
Following this preliminary assessment of meiotic resumption, oocytes were fixed in 
3:1 ethanol:acetic acid mix for four hours. The oocytes were then placed onto slides 
that contained a small amount of the fixing solution. A coverslip that had petroleum 
jelly applied at the four corners was placed over the oocytes. Pressure was slowly 
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applied to the coverslip until the oocytes were held in place but did not squash. Two 
opposite sides of the coverslip were then coated in clear nail varnish and once dry, 
the orcein stain was applied to under one side of the coverslip using a paper wick to 
draw the solution through. The slides were then kept in a humid box for between 
75 and 90 minutes. The stain was removed by applying the de-staining solution 
under the coverslip in the same manner as described above. Once the last of the 
stain had been removed, the remaining two sides of the coverslip were sealed. The 
slides were observed and photographed on a fluorescent Leica microscope. After 
morphological examination, oocytes were assessed as either being in the diplotene 
stage of prophase I (i.e. contained a GV) or in a subsequent stage of meiosis. 
2.8. Statistical Analysis 
All statistical analyses were performed using the GraphPad Prism 5 software 
program unless stated otherwise.  
For the gap junction assay, data were normalised against the mean fluorescence 
value for the control DOs in the 1 hour incubation group in each replicate 
experiment. Briefly, the mean fluorescence was calculated for the DOs in the control 
group that were incubated for a total of 1 hour in total. All the raw fluorescence 
values were then normalised by dividing the raw fluorescence values of each DO by 
the mean fluorescence value of the control DOs after the 1 hour incubation period. 
These normalised values were then checked for normality. As no transformation 
yielded a normal distribution, data was ranked and two-way ANOVA was performed 
on the ranked data. Where individual effects (either time or treatment), were found to 
be significant, either a Mann-Whitney test or a Kruskal-Wallis ANOVA with Dunn’s 
post-hoc test was performed. 
The data from the cGMP assay was analysed first by subtracting the absorbance of 
each of the samples and standards from the value of the blank (0 nM cGMP without 
the antibody). Following this, a standard curve was created by plotting the 
absorbance against the concentrations of the standards. Using the formula of the 
line of best fit for this standard curve, unknown protein concentrations were then 
calculated from the standard curve. 
As described in Section 2.6.3.2, the 2-ΔΔCT method was used to calculate the fold-
change in gene expression. This was then assessed for normality and as no 
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transformation resulted in a normal distribution, data was log-transformed in order to 
stabilise the residual variance. For PDE4D data, it was necessary to first add 1 to 
each of the values before the data was log-transformed. The transformed values 
were then fitted to a repeated measures model using the Residual Maximum 
Likelihood as implemented in GenStat (16th Edition) software. Where significant 
effects were seen for either of the main effects (either treatment or incubation 
length), further analysis was undertaken using a Kruskal-Wallis test with Dunn’s 
post-hoc tests in GraphPad Prism 5 software. 
All GVBD data are depicted in the figures as a proportion, that is, the number of 
oocytes that had undergone GVBD in relation to the total number of oocytes that had 
been cultured for each treatment. Chi squared tests were performed to determine if 
the proportion of oocytes that had initiated meiotic resumption were different. Where 
a significant effect was found, the effects (either time or treatment) were assessed 
separately using either a Chi squared test or Fisher’s exact test. 
.
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Chapter 3: Results – Optimisation Studies 
3.1. The Effect of Phosphodiesterase Inhibitors 
(Dipyradimole and Rolipram) on Gap Junction Communication 
and the Duration of Meiotic Arrest in rat COCs Cultured in vitro 
3.1.1. The Effects of Phosphodiesterase Inhibitors on Gap 
Junction Communication in Rat COCs cultured in vitro 
Incubation of rat COCs in media supplemented with phosphodiesterase inhibitors 
(dipyradimole and rolipram) resulted in increased (p<0.0001) dye transfer from the 
cumulus cells to the oocyte when compared to the control COCs. Furthermore, there 
was a significant effect (p<0.0001) of incubation time on dye transfer (Figure 3-1). 
Additionally, in both the control and phosphodiesterase inhibitor-treated COCs, 
significant decreases in fluorescent dye transfer were identified when the one and 
five hour incubation groups were compared to the 19 hour incubation group 
(p<0.0001). 
 
Figure 3-1: Fluorescent dye transfer measured in denuded oocytes following culture of rat 
COCs with or without phosphodiesterase inhibitors (DR) for 1, 5 or 19 hours. All values were 
normalised to the mean fluorescence in controls after a 1 hour incubation. For each replicate, 
10 COCs were cultured in each treatment for each time period. Bars represent mean 
normalised fluorescence ±SEM of three replicates (N=30 per group). Two-way ANOVA 
indicated a significant difference as a result of treatment (p<0.0001) and incubation length 
(p<0.0001). At each of the time points, there was a significant difference in fluorescent dye 
transfer as denoted by * (Mann-Whitney Test, * p<0.05, ** p<0.01, ***p<0.001). Furthermore, 
comparisons within the control and DR-treated groups showed that there were significant 
differences in fluorescent dye transfer over time as denoted by consecutive letter pairs (a & b 
or x & y) (Kruskal-Wallis Test, p<0.0001).  
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3.1.2. The Effects of Phosphodiesterase Inhibitors on GVBD in 
Rat COCs cultured in vitro 
Incubation of rat COCs in media supplemented with phosphodiesterase inhibitors 
(dipyradimole and rolipram) did not significantly alter GVBD rate (Figure 3-2). 
Moreover, incubation time had no overall effect on the proportion of oocytes that had 
initiated GVBD (Figure 3-2). 
 
Figure 3-2: The proportion of rat oocytes that had initiated GVBD following culture in the 
presence (DR) or absence (control) of phosphodiesterase inhibitors for 1, 5 or 19 hours. For 
each replicate experiment, 10 COCs were cultured in each treatment for each time period. Bars 
represent mean percentage GVBD ±SEM of three replicates (N=30 per group). Chi-squared 
tests indicated no significant effect of any of the treatment groups at any of the time points on 
GVBD rate were found (p>0.05).  
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3.2. The Effects of Increasing doses of C-Type Natriuretic 
Peptide (CNP), Oestradiol and Progesterone on the Duration of 
Meiotic Arrest in Rat COCs Cultured in vitro 
In order to determine the lowest effective dose for each treatment, a preliminary 
experiment was undertaken whereby a range of three doses for each of the 
treatments (i.e. CNP, oestradiol and progesterone) were tested for their effects on 
the proportions of oocytes that initiated GVBD following exposure of COCs in vitro. 
3.2.1. The Effects of Increasing Doses of CNP on GVBD in Rat COCs 
cultured in vitro 
A significant difference in the rate of meiotic resumption at the different incubation 
times was identified (Figure 3-3). While no effect of the treatments was identified 
(p>0.05), there was an effect of incubation time in both the 10 nM (p=0.0060) and 
100 nM (p=0.0130) doses of CNP after 18 hours of incubation compared to that after 
4 hours of incubation. 
 
Figure 3-3: The proportion of oocytes that had initiated GVBD following the culture of rat COCs 
with 0 (control), 1, 10 or 100 nM CNP for 4 or 18 hours. For each replicate experiment, 15 COCs 
were cultured in each treatment for each time period. Bars represent mean percentage GVBD 
±SEM of 5 replicate experiments (N=75 per group). Chi-squared tests indicated a significant 
difference between the treatment groups assessed here (p=0.0027). Fisher’s exact test 
identified significant differences in proportions of oocytes that had initiated GVBD between 
the 4 and 18 hour incubation times in the 10 and 100 nM dosage groups (as denoted by 
consecutive letter pairs, p<0.05).  
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3.2.2. The Effects of Increasing Doses of Oestradiol on GVBD in 
Rat COCs cultured in vitro 
There was a significant difference in the proportion of oocytes that resumed meiosis 
as a result of treatment of rat COCs in vitro with 0, 50, 200 or 1000 ng/mL oestradiol 
for either 4 or 18 hours (Figure 3-4). Fisher’s exact tests revealed that a higher 
proportion of oocytes had initiated GVBD after 18 hours of incubation, compared with 
4 hours of incubation in those COCs incubated with 200 and 1000 ng/mL of 
oestradiol (p=0.0207 and p=0.0321, respectively).  
 
Figure 3-4: The proportion of oocytes that had initiated GVBD following the culture of rat COCs 
with 0 (control), 50, 200 or 1000 ng/mL oestradiol for 4 or 18 hours. For each replicate 
experiment, 15 COCs were cultured in each treatment for each time period. Bars represent 
mean percentage GVBD ± SEM of five replicates (N=75-90 per group). Chi-squared tests 
indicated a significant difference between the treatment groups (p=0.0029). Fisher’s exact test 
identified significant differences in the proportions of oocytes that had initiated GVBD 
between the 4 and 18 hour incubation times in the 200 and 1000 ng/mL treated group as 
denoted by consecutive letter pairs (p<0.05).  
 
3.2.3. The Effects of Increasing Doses of Progesterone on GVBD 
in Rat COCs cultured in vitro 
There was a significant effect of treatment with different doses of progesterone on 
the proportion of oocytes that had initiated GVBD following the incubation of rat 
COCs with either 0, 50, 200 or 1000 ng/mL progesterone in vitro (Figure 3-5). 
Following an 18 hour incubation, the proportion of oocytes that had initiated GVBD 
had decreased in the 200 ng/mL treatment group when compared to the control 
group (p=0.0130). Fisher’s exact tests showed that a higher proportion of oocytes 
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had initiated GVBD after 18 hours of incubation, compared with 4 hours of incubation 
in control COCs and in the COCs that were treated with 1000 ng/mL (p=0.0068 and 
p=0.0116). 
 
Figure 3-5: The proportion of oocytes that had initiated GVBD following the culture of rat COCs 
with 0 (control), 50, 200 or 1000 ng/mL progesterone for 4 or 18 hours. For each replicate 
experiment, 15 COCs were cultured in each treatment for each time period. Bars represent 
mean percentage GVBD ± SEM of five replicates (N=75-90 per group). Chi squared tests 
indicated an overall difference in the rate of initiation of meiotic resumption between the 
treatment groups (p<0.01). Fisher’s exact test identified a significant difference between the 
control COCs and the group of COCs treated with 200 ng/mL following an 18 hour incubation 
as indicated by * (* p<0.05). Furthermore, significant differences in proportions of oocytes that 
had initiated GVBD between the 4 and 18 hour incubation times in the control COCs and COCs 
treated with 1000 ng/mL was also identified as denoted by consecutive letter pairs, (p<0.05).  
 
3.3. Outcomes from Optimisation Studies 
As a result of the optimisation studies presented here, subsequent experiments were 
performed under the conditions described below. The phosphodiesterase inhibitor 
solution was supplemented to all media for culturing the COCs in the gap junction 
assay. Therefore, this would include samples that were subsequently used for qPCR 
analyses and to assess the effects of treatments on the proportion of oocytes that 
had initiated GVBD in vitro.  
As none of the doses of CNP and oestradiol, and only the 200 ng/mL dose of 
progesterone following an 18 hour incubation, had effect on the proportions of 
oocytes that initiated GVBD in cultured rat COCs, dosages were selected based on 
published data. For example, a previous study indicated that 100 nM of CNP was 
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extremely effective at maintaining meiotic arrest in cultured mouse and pig COCs 
(Zhang et al., 2010; Kawamura et al., 2011; Hiradate et al., 2013) and thus the 
concentration of 100 nM CNP was selected for the subsequent experiments 
described herein. In terms of oestradiol and progesterone, a dose of 200 ng/mL was 
chosen as this is considered to be high but within the physiological range observed 
in rat, sheep and human follicular fluid (Goff and Henderson, 1979; McNatty et al., 
1986; Westergaard et al., 1986). 
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Chapter 4: Results –The Effects of C-Type Natriuretic Peptide 
(CNP) and Steroid Hormones on CNP/NPR2 signalling in Rat 
COCs cultured in vitro 
4.1. The Effects of Follicular-secreted Factors on Gap Junction 
Communication in Rat COCs cultured in vitro 
The results of the following experiments addressed the first aim that was to assess 
the effects of CNP and oestradiol on gap junction communication in rat COCs and 
the results are illustrated in Figure 4.1. The effects of progesterone as an alternative 
steroid hormone were also assessed. 
There was a main effect (p<0.0001) of incubation time on the levels of fluorescent 
dye measured within oocytes. Overall, fluorescent dye transfer into the oocyte 
decreased after 19 hours of incubation, when compared those incubated for 1 and 5 
hours. This reduction in dye transfer to oocytes after 19 hours incubation was 
observed for all treatment groups (depicted by different consecutive letters in 
Figure 4.1). 
There was also a main effect (p=0.0308) of treatment on the levels of fluorescent dye 
measured in oocytes. Statistical post-hoc tests revealed that this observation was 
due to a reduction in fluorescence values in those oocytes that were cultured with 
CNP alone when compared with control oocytes and was most marked after 19 
hours incubation (depicted by * in Figure 4.1). 
There was no significant interaction between treatment and incubation time on the 
levels of fluorescent dye in oocytes. 
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Figure 4-1: Mean fluorescent values ± SEM in oocytes following in vitro culture of rat COCs 
with media alone (control), CNP, oestradiol, CNP and oestradiol in combination, and CNP and 
progesterone in combination for either 1, 5 or 19 hours. Values were normalised to the average 
fluorescence value of the controls after 1 hour incubation. For each replicate experiment, 8-10 
COCs were cultured in each treatment for each time period (N=45-50 per group). A significant 
effect of treatment (p=0.0308) and incubation time (p<0.0001) was observed. Statistical post-
hoc tests indicated a reduction (p=0.0056) in oocyte fluorescence in all treatment groups after 
19 hours of incubation as denoted by different consecutive letters. Furthermore, there was 
less fluorescence (p<0.05) present in oocytes cultured with CNP alone compared to the control 
group, particularly after 19 hours of incubation as depicted by *.  
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4.2. The Effects of CNP and Oestradiol on cGMP levels in COCs 
cultured in vitro 
The results of the following experiments addressed the second aim that was to 
assess the effects of CNP and oestradiol on cGMP levels within rat COCs and are 
illustrated in Figure 4-2. 
As it was only possible to perform two replicates, statistical tests were not carried out 
on the data for the cGMP assay. In addition, although an endogenous control was 
included in each of the replicates, the control was not measurable in the second 
assay. However, because each replicate assay contained each of the treatment 
groups, comparisons were made within replicates. All results from this assay should 
thus be interpreted with caution. Notwithstanding, the data presented in Figure 4-2 
indicated that cGMP levels in COCs in all of the treatment groups were higher when 
compared to cGMP levels in control COCs. 
 
 
Figure 4-2: The levels of cGMP (fmole) per COC following in vitro culture of rat COC pools (100 
COCs) with CNP and oestradiol, alone and in combination for 5 hours.  For each replicate 
experiment, 100 COCs were cultured for 5 hours with media alone (control), CNP, oestradiol or 
CNP and oestradiol in combination (N=2).cGMP levels in these COC pools were then measured 
using a direct competitive immunoassay.  
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4.3. The Effects of CNP and Steroid Hormone Treatments on 
Cumulus Cell-Derived Gene Expression in Rat COCs Cultured in 
vitro 
The results of the following experiments addressed the third aim that was to assess 
the effects of CNP and oestradiol on mRNA expression levels of key cumulus cell-
derived candidate genes involved in the hypothesised regulatory model of meiotic 
arrest. All gene expression values were corrected against a previously validated 
reference gene (Rpl19) (Crawford and McNatty, 2012; Ekart et al., 2013). 
During the qPCR optimisation process, Pde4b was identified as being expressed at 
very low abundance even in pools of 50 COCs, despite high levels of Rpl19 
expression. Therefore, the routine procedures for optimising and validating the gene 
Pde4b for quantitative analyses were unable to be carried out accurately as the 
expression levels were outside the sensitivity of the qPCR assay. Despite this, 
Pde4b primers and probes were included within a quadriplex reaction (together with 
Pde4d, Npr2 and Rpl19) to determine any marked effects on expression of Pde4b 
due to treatment or incubation time. However, in the large majority of cumulus cell 
samples collected, the expression levels of Pde4b were undetectable regardless of 
the experimental conditions explored within this study. 
The intra-assay and inter-assay coefficient of variation (CV) was calculated for 
Pde4d and Npr2 using the ΔCT values for the calibrator samples in each qPCR run 
(the Cq value for RPL19 subtracted from the Cq value for the gene of interest). The 
intra-assay and inter-assay CV for Pde4d were 2.69 % and 0.8 %, respectively. 
Likewise, the intra-assay and inter-assay CV for Npr2 were 1.7 % and 1.67 %, 
respectively. 
 
4.3.1. The Effects of CNP and Steroid Hormone Treatments on 
Npr2 mRNA Expression in Rat Cumulus Cells 
The mRNA expression levels of cumulus cell-derived Npr2 from COCs incubated 
with media alone (control), CNP, oestradiol, CNP and oestradiol in combination, and 
CNP and progesterone in combination for either 1, 5 or 19 hours are illustrated in 
Figure 4.3. 
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There were main effects, but no interaction, of both treatment (p<0.001) and 
incubation time (p=0.047) on Npr2 expression levels. Furthermore, when compared 
to the control group, the median expression levels of Npr2 in cumulus cells of COCs 
incubated with oestradiol, CNP and oestradiol in combination, and CNP and 
progesterone in combination were significantly higher (p<0.05) than that in controls 
after 5 and 19 hours incubation, as depicted by * in Figure 4.3. Finally, statistical 
post-hoc test indicated that the cumulus cells within COCs cultured with CNP had 
increased Npr2 expression with time in incubation, as depicted by different letters in 
Figure 4.3. 
 
 
Figure 4-3: Mean relative mRNA expression levels ± SEM of Npr2 in cumulus cells of rat COCs 
incubated with media alone (control), CNP, oestradiol, CNP and oestradiol in combination, and 
CNP and progesterone in combination for either 1, 5 or 19 hours. For each replicate 
experiment, three cumulus cell samples collected for the gap junction assays were randomly 
chosen from each treatment group at each time point for subsequent gene expression 
analysis (N=11-15 per group). A significant effect of treatment (p<0.001) and incubation time 
(p=0.047) was observed. Note that Npr2 expression levels in COCs incubated with CNP 
increased significantly (p<0.05) over time, as denoted by the different letters. Also note that 
Npr2 expression levels in COCs incubated with oestradiol, CNP and oestradiol combined, and 
CNP and progesterone combined were significantly higher than the controls after 5 and 19 
hours of incubation, as denoted by * (* p<0.05, ** p<0.01, *** p<0.001).  
4.3.2. The Effects of CNP and Steroid Hormones on Pde4d mRNA 
expression in Rat Cumulus Cells 
The mRNA expression levels of cumulus cell-derived Pde4d from COCs incubated 
with media alone (control), CNP, oestradiol, CNP and oestradiol in combination, and 
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CNP and progesterone in combination for either 1, 5 or 19 hours are illustrated in 
Figure 4.4. 
There were main effects, but no interaction, of both treatment (p<0.001) and 
incubation time (p<0.001) on Pde4d mRNA levels. Treatment effects were observed 
at each incubation time point (p<0.05 for 1 and 19 hours; p<0.01 for 5 hours as 
depicted by * in Figure 4.4) but further statistical post-hoc analyses indicated that 
only COCs incubated for 1 hour with CNP and oestradiol combined expressed higher 
(p<0.05, * in Figure 4.3) Pde4d mRNA levels than that of controls. Further statistical 
comparisons to identify incubation time differences within treatment groups indicated 
that in the control and the oestradiol-treated groups, Pde4d expression levels 
decreased with time. as depicted by different consecutive letters in Figure 4.4. 
 
Figure 4-4: Mean relative mRNA expression levels ± SEM of Pde4d in cumulus cells of rat 
COCs incubated with media alone (control), CNP, oestradiol, CNP and oestradiol in 
combination, and CNP and progesterone in combination for either 1, 5 or 19 hours. For each 
replicate experiment, three cumulus cell samples collected for the gap junction assays were 
randomly chosen from each treatment group at each time point for subsequent gene 
expression analysis (N=11-15 per group). A significant effect of both treatment (p<0.001) and 
incubation time (p<0.001) were observed. Within each of the incubation times, there were 
significant differences between treatments, as indicated by *. Statistical post-hoc tests 
indicated significantly higher expression levels (p<0.05) of Pde4d in COCs incubated with CNP 
and oestradiol combined, compared to controls after 1 hour incubation (depicted by *). Within 
the different treatment groups, Pde4d mRNA levels decreased with time (p<0.05) in the COCs 
incubated with media alone (controls) and with oestradiol alone as indicated by different 
consecutive letters (p<0.05).  
 
1 5 19
0
5
10
15
Control
CNP
Oestradiol
CNP + Oest
CNP + Prog
 
Time (Hours)
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
re
s
s
io
n
* ** *
*
a
a
b
o
o
p
46 
 
4.4. The Effect of CNP and Steroid Hormones on GVBD in Rat 
COCs cultured in vitro 
The results of the following experiments addressed the fourth aim that was to assess 
the effects of CNP and oestradiol on the prevention of spontaneous meiotic 
resumption in COCs extracted from follicles and cultured in vitro by assessing the 
proportion of oocytes that had a visible GV with increasing time in culture. 
The proportion of oocytes that had initiated GVBD in cultured rat COCs was found to 
be different in the treatment groups assessed in this study (Figure 4.5). In particular, 
a significant difference was identified in the GVBD rate between the treatment 
groups following a 5 hour incubation (p=0.0042). Within the groups that had been 
incubated for 5 hours with the treatments, only the CNP and oestradiol in 
combination and the CNP and progesterone in combination had significantly 
increased rates of meiotic resumption when compared to the controls (p=0.0063 and 
p=0.0243, respectively). Note that these COCs were incubated in media containing 
phosphodiesterase inhibitors. 
 
Figure 4-5: Mean proportions (%) ± SEM of rat oocytes with or without (GVBD) a visible 
germinal vesicle in rat COCs incubated with media alone (control), CNP, oestradiol, CNP and 
oestradiol in combination, and CNP and progesterone in combination for either 1, 5 or 19 
hours. For each replicate experiment, 8-10 COCs were cultured in each treatment for each time 
period (N=45-50 per group). An effect of treatment regime on the duration of meiotic arrest was 
found (p=0.0265). Furthermore, Chi squares tests indicated that there was a difference 
between the treatment groups within the 5 hour incubation group (p=0.0042). This difference 
was found when comparing the rate of GVBD in the CNP and oestradiol combination, and CNP 
and progesterone combination treated COCs with control COCs as indicated by * (*p<0.05, 
**p<0.01, ***p<0.001).  
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4.4.1. The Effect of CNP and Oestradiol on the Duration of Meiotic 
Arrest without Phosphodiesterase Inhibitor 
Supplementation 
The combined effects of CNP and oestradiol on the rates of meiotic resumption were 
assessed without phosphodiesterase inhibitor supplementation in order to determine 
whether CNP and oestradiol could indeed modulate the rate of meiotic resumption 
and whether the phosphodiesterase inhibitor solution was altering the sensitivity of 
rat COCs cultured in vitro to meiosis inhibiting compounds (Figure 4-6).  
The proportion of rat oocytes that had initiated GVBD was significantly different 
between the groups assessed in this study (p<0.0001). Following a 5 hour 
incubation, the oocytes in the control group had significantly higher levels of GVBD 
compared to freshly isolated oocytes (control at 0 hours) (p<0.0001). Additionally, 
the COCs incubated for 5 hours with CNP and oestradiol in combination had a 
significantly lower rate of meiotic resumption when compared to the control group 
(p=0.0329). 
For further investigation of the effects of CNP and oestradiol on the timing of meiotic 
resumption, an orcein staining technique was used. Despite being unable to 
investigate the stage of meiosis in all of the oocytes used in the above experiment, 
all oocytes that were assessed using this technique confirmed that the original 
assessment of the meiotic status (GV or GVBD) of these oocytes was correct (Figure 
4-7 and Figure 4-8). 
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Figure 4-6: Mean proportions (%) ± SEM of rat oocytes with or without (GVBD) a visible 
germinal vesicle of rat COCs that were assessed immediately following collection, or following 
a 5 hour incubation with media alone (control), or CNP and oestradiol in combination. For each 
replicate experiment, 11-12 COCs were cultured in each treatment for each time period (N=35-
36 per group). Fisher’s exact test identified a significant difference in the rate of initiation of 
GVBD between the treatment groups (p<0.0001). Note a significant increase in GVBD in the 
control group over time (* p<0.05, **p<0.01, *** p<0.0001). A significant difference between the 
treatment groups was found using Fisher’s exact test, as indicated by the different 
consecutive letters (p<0.05).  
 
 
Figure 4-7: Photomicrographs of denuded rat oocytes in the germinal vesicle (GV) stage 
stained with orcein. COCs used in the experiment depicted in Figure 4-6 were assessed for the 
presence of a GV and then stained using the orcein staining protocol. The visible nucleolus (a 
characteristic of GV stage oocytes) is indicated by the white arrow. In A and B filamentous 
chromatin can be seen in the cytoplasm around the nucleolus but this is not clear in C due to 
the oocyte being more darkly stained.  
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Figure 4-8: Photomicrographs of denuded rat oocytes that have initiated germinal vesicle 
breakdown (GVBD). COCs used in the experiment depicted in Figure 4-6 were assessed for the 
presence of a GV and then stained using the orcein staining protocol. The oocyte in A has 
initiated GVBD; the chromosomes are condensed indicating the end of meiotic arrest and 
prophase I. The oocyte in B has initiated GVBD and appears to be at metaphase I or anaphase I 
stage of meiosis. Note the black square pictured above functioned as part of the CRAIC 
fluorescence detection system and could not be removed in these photomicrographs.  
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Chapter 5: Discussion 
The overall aim of this study was to elucidate the validity of a hypothesised 
regulatory pathway, illustrated in Figure 1-5, to explain the regulation of meiotic 
arrest in a rat model. In this hypothesised mechanism, CNP activates its high-affinity 
receptor, NPR2, located on cumulus cells to stimulate the synthesis of cGMP. Cyclic 
GMP is transferred to the oocyte via gap junctions where it slows the hydrolysis of 
cAMP by PDE3A. In antral follicles, the granulosa cells produce oestradiol, which 
increases the numbers of NPR2 which further increases cGMP production resulting 
in a prolonged inhibition of meiotic resumption. In order to assess the validity of this 
hypothesis in the rat, this study investigated four fundamental components of this 
regulatory mechanism. The first component of the pathway investigated was that of 
gap junction communication. Specifically, CNP and oestradiol were assessed for 
short- (4 and 5 hour incubations) and long- (18 and 19 hours) term effects on gap 
junction permeability. Secondly, in terms of this hypothesised model, it was important 
to determine whether treatment of rat COCs with CNP and oestradiol alone and in 
combination resulted in measurable increases in cGMP levels in COCs The third 
component investigated was whether CNP and oestradiol were able to modulate, 
following short and long incubations with COCs, the expression levels of the key 
genes Npr2, Pde4b and Pde4d. The final component investigated in this study were 
the effects of CNP and oestradiol, alone and in combination, on the duration of 
meiotic arrest and whether this was delayed in response to the aforementioned 
treatments. Only by investigating these four aspects, can the validity of the 
hypothesised pathway be vigorously assessed in the rat model. 
Gap junction permeability is critical to the hypothesised model. If gap junction 
communication between the cumulus cells and oocyte is impaired, any 
CNP-mediated changes in cGMP levels within cumulus cells may not relayed into 
the oocyte to assist in the inhibition of cAMP hydrolysis by PDE3A. The results 
presented herein reveal that in spite of a significant decrease in gap junction 
permeability in cultured COCs with time, it is possible that there is sufficient gap 
junction communication to allow regulatory molecules, such as cGMP to be 
transferred to the oocytes at levels that are sufficient to prevent meiotic resumption. 
A previous report on bovine gap junction permeability indicated that meiotic 
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resumption in response to loss of gap junction communication occurred once calcein 
transfer dropped to below 40% of the original levels measured (Thomas et al., 2004). 
Therefore, while none of the treatments increased gap junction permeability, this 
study provides an indication that in rat COCs, sufficient gap junction permeability is 
maintained to allow for the transfer of cGMP to the oocyte even following 19 hours of 
culture. The results presented in this study are in agreement with previous reports in 
a number of mammalian species indicating reduced gap junction permeability in 
COCs over time, especially following prolonged (≥18 hours) in vitro culture (e.g. in 
rats, Campen, 2013; pigs, Sasseville et al., 2009; and cows, Thomas et al., 2004).  
As discussed previously, the basis of the hypothesised regulatory model was that 
cGMP levels increased in both the cumulus cell and oocyte compartments of mouse 
COCs following treatment with CNP. Interestingly, previous evidence indicated that 
treatment with CNP alone increased cGMP levels in freshly isolated COCs in both 
the cumulus cell and oocyte compartments, but this effect was transient. In order to 
elicit sustained increases in cGMP levels, treatment with a combination of CNP and 
oestradiol was required (Zhang et al., 2011). Moreover, it has also been shown that 
both cGMP and CNP protein levels and Npr2 mRNA are modulated during oestrous 
cycling in the rat (Jankowski et al., 1997; Gutkowska et al., 1999). In particular, the 
highest levels are observed around proestrous, indicating that high levels of 
oestradiol influence cGMP levels and that it is possible that this occurs via the 
pathway being investigated in this report. The results presented herein provide an 
indication that CNP may increase cGMP levels in COCs, and it also indicates that 
oestradiol may also modulate cGMP levels as well. Due to logistical constraints and 
the limited amount of time available to optimise this assay, only two replicates were 
performed. In order to be able to conclusively determine the effect of these 
treatments on cGMP levels in COCs, further investigation would be required. 
However, in combination with the results presented for the gene expression studies 
for Npr2, the results of the cGMP assay give a preliminary indication that cGMP 
levels were increased in response to treatment of rat COCs with CNP and oestradiol. 
To ascertain indirectly the levels of cGMP within the cumulus cells and to establish a 
role of oestradiol in the hypothesised pathway, mRNA expression levels of Npr2 
were quantified in cultured rat COCs. While there are a number of other guanylyl 
cyclase receptors (both membrane bound and soluble) that have been identified in 
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rat and mouse follicles, these are significantly lower in abundance and have been 
shown to contribute little to the follicular cGMP levels when compared to NPR2 
(Noubani et al., 2000; Robinson et al., 2012). Moreover, Npr2 mRNA expression has 
been shown to be modulated during the oestrous cycle and particularly in response 
to gonadotropins (Jankowski et al., 1997; Gutkowska et al., 1999; Kawamura et al., 
2011; Robinson et al., 2012). The results presented herein reveal that exposure of 
COCs to oestradiol alone, CNP and oestradiol in combination, and CNP and 
progesterone in combination increased Npr2 mRNA expression levels following 5 
and 19 hours of incubation. These results are in agreement with previous reports in 
which treatment of mouse and rat COCs with oestradiol and DES increased Npr2 
mRNA expression levels in the cumulus cells, compared to untreated controls 
(Noubani et al., 2000; Zhang et al., 2011). Although treatment with progesterone 
alone had previously been shown to have no effect on Npr2 mRNA expression levels 
(Zhang et al., 2011), the current study showed that treatment of rat COCs with CNP 
and progesterone in combination increased cumulus cell Npr2 mRNA levels. It is 
important to note however that other studies used significantly lower doses of steroid 
hormones (~7 fold less of oestradiol and ~6 fold less of progesterone). Moreover, in 
this study, only cumulus cells from the CNP-treated group showed increased Npr2 
mRNA expression over time. This could indicate that CNP alone is able to modulate 
Npr2 mRNA levels over time and may explain why in the study described herein, 
treatment with CNP and oestradiol had a greater effect than oestradiol alone, and 
that CNP and progesterone in combination increased Npr2 levels as well. It would 
have been particularly useful to assess the effects of progesterone alone on Npr2 
expression in cultured cumulus cells in this study however time and logistical 
constraints deemed this not possible.  
It is widely accepted that phosphodiesterases play an integral role in the regulation 
of meiotic resumption both in vitro and in vivo. However the effects of steroid 
hormones and phosphodiesterase inhibitors on phosphodiesterase activity and the 
duration of meiotic arrest are not well understood in the rat. The phosphodiesterase 
isoforms PDE4B and PDE4D have been identified in the follicular somatic cells of 
rats. The gene expression results reported herein indicate that Pde4b mRNA levels 
are expressed in very low abundance. While it was possible to measure Pde4b 
mRNA expression levels in larger pools of COCs, it was not possible in cumulus 
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cells derived from a single COC. Nevertheless, this study has confirmed that Pde4b 
mRNA is expressed in rat cumulus cells, albeit at very low levels. 
From previous reports, there is strong evidence to suggest that PDE4D is influential 
in the regulation of meiotic resumption. Indeed, the loss of PDE4D function 
significantly affects female fertility as studied in a number of mouse knockout models 
and this is postulated to be due to disruption of the temporal pattern of cAMP levels 
(Jin et al., 1999). This evidence also includes the up-regulation of Pde4d mRNA and 
increased cAMP-hydrolysing activity in granulosa cells under gonadotropin 
stimulation (Jin et al., 1999; Park et al., 2003). This study reported herein confirmed 
that Pde4d is expressed in rat cumulus cells and that Pde4d expression levels varied 
significantly over the different incubation times and in response to the various 
treatments. However overall, the treatments that consistently increased Pde4d 
mRNA levels all contained CNP (i.e. CNP alone, CNP and oestradiol combined, and 
CNP and progesterone combined). Moreover, CNP and oestradiol combined 
resulted in the largest increase in Pde4d mRNA, compared to that in controls, after 1 
and 19 hours in culture. The expression levels of Pde4d in the control and oestradiol-
treated groups were the only groups that changed significantly with time in culture. 
Both of these groups showed a similar pattern of expression whereby a decrease in 
expression was observed following the 19 hours incubation, compared to that after 1 
and 5 hours incubation. It is possible that in the other groups, the addition of CNP to 
the treatments may have masked this effect through modulation of cumulus cell-
derived cGMP and perhaps cAMP levels that may stimulate Pde4d mRNA 
expression levels. 
The differential responsiveness of PDE4D to signalling by LH and FSH could 
indicate a mechanism by which increases in cAMP result in different outcomes in 
response to these signals (Jin et al., 1999; Park et al., 2003). Following FSH and LH 
stimulation in mice, it has been shown that Pde4d mRNA is upregulated and this is 
thought to be important for ensuring that concomitant increases in cAMP are 
transient (Park et al., 2003). The consensus is that the specificity of the gonadotropin 
signal is encoded in both fluctuations in the levels of cAMP in the follicle as well as 
the temporal patterns of cAMP concentration fluctuations. Park et al. (2003) 
hypothesised that due to the fact that Pde4d-/- mice are unresponsive to LH 
signalling but still responsive to adenylyl cyclase stimulation that the impairment in 
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LH signalling must be due to desensitisation or down-regulation of the LH receptor 
due to loss of PDE4D function. Therefore, evidence from this, and previous, studies 
support the notion that PDE4D is most likely to be regulated by a number of different 
pathways that are involved in the regulation of cAMP levels in the follicle, including 
gonadotropin signalling pathways (Park et al., 2003) and possibly the CNP/NPR2 
regulatory pathway.  
Finally, to fully evaluate the validity of this hypothesised model in the rat, it was 
essential to assess the effects of CNP and/or steroid hormones on the duration of 
meiotic arrest in cultured COCs. Interestingly in this study, the timing of GVBD 
initiation was modulated by the CNP and oestradiol in combination, and by CNP and 
progesterone in combination, following the 5 hour incubation. Furthermore, there 
was no effect of time on GVBD initiation. These results were inconsistent with 
previous reports (Zhang et al., 2010; Kawamura et al., 2011) and this effect is likely 
due to the supplementation of culture media with dipyradimole and rolipram. The 
addition of these phosphodiesterase inhibitors was probably not appropriate for 
studying the timing of meiotic resumption in cultured COCs, but for the gap junction 
assay was necessary to prevent spontaneous meiotic resumption which is known to 
occur in rat COCs after 1-2 hours of in vitro culture (Wert and Larsen, 1989).  The 
aim of phosphodiesterase inhibitor supplementation in context of the gap junction 
assays was to maintain meiotic arrest and gap junction communication in these 
cultured COCs over time such that these COCs remained sensitive, in terms of gap 
junction activity, to the effects of the treatments. In this, and previous, studies 
supplementation with dipyradimole and rolipram was shown to maintain gap junction 
communication in cultured COCs but did not alter the timing of meiotic resumption 
(Campen, 2013). There is extensive evidence in mouse models and limited evidence 
from a pig model, that the presence of CNP reduces the incidence of meiotic 
resumption in a dose-dependent manner (Zhang et al., 2010, 2011; Kawamura et al., 
2011; Hiradate et al., 2013) while using a range of doses that are equivalent to those 
used in this study (1, 10 and 100 nM). However, in these studies COCs were 
cultured in media absent of phosphodiesterase inhibitors or supplemented with the 
broad spectrum phosphodiesterase inhibitor, IBMX, which is largely ineffective at 
maintaining meiotic arrest in rat oocytes (Bilodeau-Goeseels, 2011; Downs, 2011).  
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Thus, in order to overcome the masking of treatment effects by the presence of 
phosphodiesterase inhibitors, a further experiment was carried out to assess solely 
the timing of meiotic resumption in COCs that were cultured in media without these 
phosphodiesterase inhibitors. Due to logistical constraints, only one treatment was 
selected to be tested in comparison to controls. Collectively, the treatment that 
showed the largest influence on the other parameters tested within this study was 
CNP and oestradiol combined. An incubation time of 5 hours was chosen to allow 
enough time for untreated COCs to initiate GVBD as well as allow the treatment to 
have an effect. In addition, the incubation time of 5 hours had previously been shown 
to be successful in observing modulation of GVBD timing by these treatments 
(Kawamura et al., 2011). This experiment showed that treatment with CNP and 
oestradiol decreased GVBD rate significantly compared to the control COCs. 
Moreover, an effect of time was observed when comparing GVBD rate in the control 
COCs. Subsequently, an orcein staining technique was used to confirm that 
preliminary assessment of meiotic resumption was justified in all of the oocytes that 
were stained as well. As a consequence of these results, supplementation of media 
with phosphodiesterase inhibitors was also excluded from the experiments that 
assessed treatment effects on the levels of cGMP within rat COCs.  
In summary, this study provides further evidence that the aforementioned 
hypothesised model of regulation of the duration of meiotic arrest is relevant to the 
rat. While gap junction permeability was not increased by any of the treatments 
tested herein, there was sufficient gap junction communication to allow for transfer of 
molecules such as cGMP from the cumulus cells to the oocyte. This study also 
indicated that cGMP levels, using both direct and indirect measurements, may be 
increased in rat COCs in response to treatment with CNP and oestradiol. 
Correspondingly, oestradiol (with or without CNP) and possibly progesterone 
upregulated Npr2 mRNA expression in rat cumulus cells. Interestingly, Pde4d 
expression was complex and perhaps multi-faceted, however all treatments that 
contained CNP appeared to consistently stimulate Pde4d expression levels 
suggesting that an increase in cGMP levels via CNP stimulation results in an up-
regulation of Pde4d mRNA. This is likely to be part of a feed-back loop that regulates 
fluctuations in cGMP levels. Finally, this study confirms that CNP together with 
oestradiol prolongs the duration of meiotic arrest in rat COCs after 5 hours in culture. 
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This study has highlighted the complexity and lack of knowledge surrounding the role 
phosphodiesterases in meiotic resumption and other pertinent phosphodiesterases 
may be involved in the regulation of meiotic resumption in rats. 
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Chapter 6: Conclusions and Future Directions 
Overall the results of this study indicate that while CNP and oestradiol did not 
increase gap junction permeability in rat COCs in vitro, it was possible that these 
treatments increased the production of cGMP, however this requires further 
investigation. Notably, this study confirmed the role of oestradiol in upregulating Npr2 
expression and that treatment of rat COCs with CNP and oestradiol delayed meiotic 
resumption in vitro. 
The gene expression study revealed a number of interesting results including a 
possible role for progesterone and CNP in the regulation Npr2 expression. In 
addition, Pde4d expression was shown to be highly variable and suggested a 
possible negative feedback loop as all treatments that included CNP, thus increasing 
intracellular cyclic nucleotide levels, also appeared to increase Pde4d expression 
levels. 
While the results presented herein have been useful in evaluating the validity of the 
hypothesis, they have also raised a number of questions that warrant further 
investigation. Further studies to confirm the stimulatory action of CNP and oestradiol 
on cGMP levels in COCs are required. In addition, it would be particularly useful to 
identify whether these treatments increase cGMP levels in the cumulus cells which is 
then subsequently transferred into the oocyte as stipulated in the model. Another 
area for further investigation would be the effect of progesterone alone and in 
combination with CNP, on Npr2 mRNA expression levels. Unfortunately the logistics 
of the study described herein did not allow for an investigation into the effects of 
progesterone alone on Npr2 expression levels.  
Despite this, the major limitation for this study was the unexpected effects of the 
phosphodiesterase inhibitors dipyradimole and rolipram on the duration of meiotic 
arrest in cultured COCs. Previous studies within our laboratory revealed that gap 
junction permeability was improved with the addition of these phosphodiesterase 
inhibitors (Campen, 2013). One strength of this study was that measurements of gap 
junction permeability, duration of meiotic arrest and gene expression levels were 
collected from the same individual COC so that these results could be directly 
compared. Unfortunately a weakness of this experimental design was that all these 
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samples were cultured in the presence of phosphodiesterase inhibitors. Due to 
logistical constraints, it was not possible to assess the effects of all the treatment 
combinations (treatment and incubation times) on the duration of meiotic arrest 
without the influence of the phosphodiesterase inhibitors. This may provide further 
information about the effects of progesterone in this mechanism. Moreover, because 
rolipram is a PDE4-specific phosphodiesterase inhibitor, it would be worthwhile to 
investigate whether treatment with the phosphodiesterase inhibitors modulates the 
expression of Pde4b and Pde4d. 
In conclusion, the results of this study provide evidence that the hypothesised 
mechanism that regulates meiotic resumption in mice is also relevant in the rat. 
These results also provide an insight into the complexities of the regulation of meiotic 
arrest and indicate phosphodiesterases are likely to have a major role to play in this 
mechanism.  
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